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ABSTRACT 
Cervical cancer is the second most prevalent cancer amongst women worldwide. 
Almost 99% of all cervical carcinomas have been linked to Human Papillomavirus 
(HPV). The various types of HPV can be distinguished between those that have a 
high-risk of causing cancer and low-risk. HPV -16 is high-risk and has been found 
to coincide with 60% of cervical carcinomas. The native virion contains two 
structural proteins; L 1 and L2. L 1 has been extensively characterized and has the 
ability to form virus-like particles (VLPs), a phenomenon currently available 
vaccines exploit. However, the immune response against L 1 was found to be type-
specific necessitating multivalent vaccines. In contrast, L2 has shown cross 
protection against different HPV types. In addition, it appears to enhance capsid 
formation making it an ideal candidate for a recombinantly expressed vaccine 
and/or vaccine enhancer. 
Currently, the available vaccines are expenSIve, thus beyond the reach of 
developing countries where the vaccine is needed most. This is in part, due to the 
expensive expression system used in their production. Plant production provides a 
possibly cheaper platform. This study demonstrates high level expression of L2, 
25 mg.kg- l of leaf material, is achievable. Interestingly, expression was best when 
coded for by a mammalian codon-optimized form of the L2 gene as opposed to the 
wildtype or plant codon-optimized (plantized) genes. Moreover, real time PCR 
revealed limited levels of transcript when coded for by the plantized gene in 
comparison to the other genes. A set of vectors which target the protein to the 
cytoplasm, the endoplasmic reticulum (ER), chloroplast or apoplastic space were 
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used and it was found that targeting of the protein had no effect on its expression 
levels. Furthennore, the results indicate a possible mitochondrial-targeting site in 
the N-tenninus of the L2 protein, specifically recognized in plants, which may 
interfere with targeting to the ER and apoplastic space. However, targeting to the 
chloroplast appears to be unaffected. 
Finally, co-expreSSIOn of LI and L2 was found to be possible in this system 
making fonnation ofLl/L2 VLPs highly probable. This study represents the initial 
steps towards realizing the feasibility of a plant produced HPV L lIL2 vaccine that 
may be cheaper and more effective. 










Expression of HPV -16 L2 in Plants 
ACKNOWLEDGMENTS 
I would like to formally thank the following: 
My supervIsor Prof Ed Rybicki, for his consistent help and steady guidance 
throughout. 
My co-supervisor Dr Inga Becker, for her unwavering support and motivation 
when I needed it most. 
My other co-supervisor, Dr James Maclean, for his valuable input and 
willingness to assist wherever possible. 
The various lab members in the virology lab of the MCB department who were 
always willing to go beyond merely teaching a new technique. 
Dr Suhail Rafudeen and Dermot Cox for their help in both formulating and 
interpreting the real time PCR work. 
Keren Cooper and Mohammed Jaffer for their assistance III perfecting the 
electron microscopy technique, proving that with patience and tenacity it is 
possible to do your own EM work. 
In addition, my grandfather, Clive DeWitt, to whom this thesis is dedicated, for 
his support, both financial and personal. Although, at times unsure, he has always 
had my best interests at heart and I thank him for the incredible opportunities he 
has constantly provided me with. 
Finally, I would like to thank the Poliomyelitis Research Fund for providing the 
funding awarded to Ed Rybicki for this study. 










Expression of HPV -16 L2 in Plants 
1. CHAPTER 1 
LITERATURE REVIEW 
1. 1 Introduction 
The idea of a virus causing cancer is not a novel one; an estimated 15-20% of all 
cancers are directly linked to various viruses (41). Cervical cancer is the second 
most prevalent cancer amongst women worldwide with over 470,000 new cases 
reported annually and almost half that number dying in the same time (55). 
Cytological screens of cervical tumours have detected Human Papillomavirus 
(HPV) DNA in 99.7% of these cases (78). HPV has also been implicated in 85% 
of anal cancers; 50% of cancers of the vulva, vagina and penis; 20% of 
oropharyngeal cancers; and 10% of laryngeal and esophageal cancers (78). In 
addition, ~20 million people are infected with HPV in the US at anyone time, 
making it the most commonly diagnosed, sexually transmitted disease (55,78). 
HPVs belong to the genus Papillomavirus, which are known to infect a large 
number of mammals and birds (26). Papillomaviruses (PVs) have a natural 
tropism for epithelial cells, often entering through an abrasion that exposes the 
lower layers of the epithelium, more than likely targeting the stem cells in the 
basal layer (72,74). Humans are the most extensively studied host of PVs, with 
over 120 HPVs that have been characterized and many more thought to exist 
(26,78). HPVs are further divided into those infecting cutaneous or mucosal 
epithelium, with ~40 mucosal HPVs having been described (78). It is these HPVs 
infecting the mucosa of the anogenital tract that have raised concern. 
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Infection is characterized by unsightly genital warts, which are painful and costly 
to remove. Majority of infections are cleared naturally, with the wart 
spontaneously regressing; however, persistent infections could lead to 
carcinogenic development (55,74,78). HPVs that infect the mucosa are further 
subdivided into two groups, high-risk and low-risk, according to their propensity 
of infection to lead to a carcinoma developing. Low-risk HPV s such as HPV -6 and 
HPV -11 cause benign genital warts and are classified as possibly causing cancer 
(26). High-risk types include HPV-16, accounting for 60% of all cervical cancer 
cases, HPV-18, accounting for 10-20%, and HPV types 31, 33, 35, 39,45,51,52, 
56, 58, 59, 68, and 73, which account for the rest of cervical cancer cases 
(55,64,78). It is evident that a broad spectrum vaccine would be ideal to 
completely eradicate cervical cancer. 
Two vaccmes are presently available in certain countries which have proven 
highly effective at preventing HPV infection in human trials (74,78). A general 
vaccine model has been proposed: vaccination of females at age 12 and triennial 
cytological screening from age 25 (82). Using this model, a 94% decrease in 
cervical cancer deaths has been predicted if the vaccine is only 70% efficacious 
(82). Detection of abnormal cytology in papinocolau (pap) smears has lead to a 
marked decrease in cervical cancer cases in developed countries, coupled with the 
availability of vaccines; research in "first-world" countries will begin to wane. 
However, due to the socio-economic context within developing countries research 
into more effective, cheaper vaccines with possibly broader, cross-neutralizing 
activities will be emphasized. 
Vaccine design has pivoted on the exquisite fusion of microbiology and 
immunology. As technology advances, "second generation" vaccines are 
inevitable, these will seek to decrease the cost of the vaccine and broaden the 
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of HPV has shown promise in both aspects. This chapter will attempt to explain 
where L2 fits into both the structure and the HPV life cycle and explain its 
relevant immunogenic properties. 
1.2 The Viral Life Cycle: The role of L2 
1.2.1 The Structure of the HPV Virion 
The viral capsid structure is elegantly simple, yet at the same time complicated to 
conceptualize; understanding it, however, is necessary to get closer to designing a 
vaccine. The easiest way to comprehend the structure of the viral capsid is to use 
an analogy for the various terms used. The capsid proteins/molecules/monomers 
are the bricks; the capsomeres are the walls; the capsomers are the rooms; and the 
capsid is the house. 
The HPV capsid is icosahedral in shape and arranged in a T=7 right-hand skew 
lattice (37). Only two proteins make up the capsid; the major capsid protein (L1) 
and the minor capsid protein (L2). Three hundred and sixty (360) molecules of L 1 
make up the capsid whilst the amount of L2 incorporated is unclear. The 
stoichiometric ratio of Ll:L2 is speculated to be 30:1, meaning twelve L2 
molecules per capsid (13,92). Five L1 molecules associate to form a 
pentamer/capsomere; each containing a hole in the centre in which the L2 may 
associate (13). L2 molecules appear to interact with each other in an 
intercapsomeric-dependent manner with the C-terminal of one molecule 
interacting with the N-terminal of another (13). 
72 capsomeres make up the capsid; it is postulated that each L 1 molecule in a 
capsomer contains a C-terminal tail that invades a neighbouring L 1 molecule in ltD 
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The L 1 protein contains the intrinsic knowledge to form the capsid structure; 
allowing it to form virus-like particles (VLPs) that mimic the native virion 
structure (18). VLPs can form in the presence or absence of L2 and other cellular 
factors (18,37). Comparably, L 1 alone VLPs have been noted to be more variable 
in size and shape than L 1 and L2 expressed VLPs, leading to speculation that L2 
enhances capsid formation (18,37). L2 may possibly act as a nucleating structure 
and allow formation at a more physiological pH (18,37). Cellular factors, such as 
hsp70 and several other chaperones have also been implicated and may aid capsid 
formation by facilitating the C-terminal invading arm (18,37). 
The L2 protein acts to localize the vanous cellular components and viral 
components to nuclear domain 10 (ND 1 0) sites within the nucleus which appears 
necessary for virion production in vivo (30,34). However, recent studies have 
shown that L2 in frozen wart and raft culture sections is localized rather to the 
nucleus than specifically to ND 1 0 domains. L2 has also been implicated in aiding 
encapsidation of viral DNA. The HPV genome associates with cellular histones 
and may serve as a scaffold for capsid formation (18). 
1.2.2 Viral Entry 
The infectious Vlflon is bound to the epithelial cell VIa the heparan sulphate 
receptor which recognizes a surface loop exposed on Ll (10). Ll-alone VLPs are 
noted to be able to enter a number of cells; however, infectivity is increased with 
L2 co-expression (42). This may be due to a stabilizing effect of L2 or possibly 
indicate a secondary receptor binding motif within L2 (42). A surface binding 
region in L2 has been described but it is unclear to which receptor it binds (92). 
The infectious virion is internalized by clathrin-dependent endocytosis (44). The 
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exposing the N-terminal region of L2 - normally hidden by the capsomere (65). A 
proprotein convertase, furin, cleaves the L2 at a specific site, removing the first 
nine amino acids (65). This cleavage may facilitate a further conformational 
change allowing an as yet unidentified secondary-binding receptor recognition 
close to the N-terminal of the protein (92). This is evidenced by a monoclonal 
antibody against HPV-16 L2 that prevents internalization, most probably by 
preventing binding of the secondary receptor (24). 
The cleavage and/or secondary-binding could allow the L2 and HPV genome 
complex to free itself of L 1, and allow a membrane destabilizing peptide located 
in the C-terminal ofL2 to allow egress of the complex from the endosome (44). A 
region in the N-terminal also interacts with tSNARE Syntaxin 18 which may 
facilitate movement to the nucleus (9). A C-terminal region has also been 
identified as binding to Dynein, a microtubule motor protein, which may also aid 
movement of the L2-HPV genome complex to the nucleus (Fig. 2) (29). This 
theory of viral entry has many unanswered questions; however, the importance of 
L2 is undeniable. 
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Although small, the HPV genome is tightly controlled and regulated, coding for 
only eight viral proteins that are read in all 3 frames. An untranslated long control 
region (LCR) rigorously controls gene expression (41). These proteins are further 
divided according to which stage of the viral life cycle they are expressed (72). 
The early proteins; El, E2, E5, E6, and E7 are expressed in the basal and 
suprabasal cell layer and are involved in DNA replication, transcription and cell 
immortalization (Fig. 3) (55,72,74). 
EI and E2 are involved in DNA replication and transcription. HPV requires the 
host machinery to replicate its DNA; hence it needs to transform the differentiated 
cell, which has normally exited the cell cycle (8). E6 and E7 are involved in 
immortalization of the cell and interact with p53 and retinoblastoma (RB), 
respectively (55,72). E6 binds p53 and forces its degradation so disrupting its 
function as a tumour suppressor, it also acts to ensure telomeres are kept at their 
critical length (55,72). E7 competitively binds to RB, preventing it from 
negatively acting on the cell cycle (55,72). Both E6 and E7 have proven to be the 
potent oncogenes that lead to carcinoma development. Interestingly, the E6 and E7 
proteins found in the high-risk HPV s differ by only one amino acid from those 
found in low-risk HPVs. (72) E5 is indirectly involved in tumour progression by 
sequestering the heavy chain of MHC I molecules in the Golgi, so aiding immune 
evasion (15). 
Expression of all the HPV genes is exquisitely controlled, but the true success of 
the virus is determined by how well it can control the expression of its late genes, 
E4, L 1, and L2. The late genes, in particular L 1 and L2, are responsible for 
inducing an immune response to clear infection. E4 is believed to be involved in 
assisting escape of mature virions from the cell (55,72). As mentioned previously, 
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the capsid is made up of both L 1 and L2; a number of methods are employed by 
the HPV genome to regulate the expression of these two genes. 
Multiple promoters in the HPV genome allow the precise expression of the various 
genes. A family of promoters and regulatory regions are located in the LCR and 
function to control expression of early genes (72). Expression of late genes is 
controlled by regulatory regions in the LCR but the differentiation signal is 
thought to be closer to the late promoter located in the E7 gene (8). As a further 
control the late promoter is only functional in differentiated cells (8). 
In addition, two separate polyadenylation signals are used by the early genes 
(pAE) and by the late genes (pAL). The pAE is located in the L2 gene; 
immediately downstream thereof are a number of GGG motifs that enhance the 
functioning of the pAE (61). If these GGG motifs are mutated read-through of the 
late genes occurs (61). The GGG motifs allow binding of hnRNP H which recruits 
various factors to allow splicing - another method of control (61). The HPV 
genome contains a number of splice sites that produce a varied number of mRNA 
products that can be selectively spliced according to the differentiation of the cell 
(68). For example, hnRNP H is abundantly found in the basal layer so the pAE is 
spliced into the early gene mRNAs leading to their expression (61). Expression of 
hnRNP H decreases as cells differentiate leading to the pAE not being used and 
allowing splicing of the late gene mRNAs with the pAL (61). This model supports 
the possibility of hnRNP H as a differentiation-dependent factor (61). 
Recently methylation of the HPV genome has been implicated in controlling 
expression. Methylation may act to inhibit gene expression by directly preventing 
transcription factors from binding and/or indirectly allowing more complicated 
DNA structures to form that are not readily accessible by polymerases (4,79). The 
HPV genome has 40% GC content, therefore 400 sites for methylation (CpG sites) 










Expression of HPV -16 L2 in Plants 
are expected to occur randomly yet there are only 172 indicating their positions to 
be highly specific. Methylation was found predominantly in the LCR and the Ll 
gene. Interestingly, decrease in differentiated cells that are showing symptomatic 
infection; further enhancing the differentiation-dependent control. Furthermore, 
the HPV genome is hypermethylated with carcinoma development (80). 
The HPV genome has the ability to integrate into the chromosomal DNA which 
more than likely happens due to the natural selection occurring due to the 
immunological response, such that integration is a means of escaping (74). 
Integration occurs at a particular site within the E2 gene disrupting its expression, 
this leads to an increase in E6 and E7 expression which is normally negatively-
regulated by E2 (72). The L 1 gene and rest of the genome have been noted to be 
hypermethylated upon integration but it is unsure if this is due to the integration 
into cellular DNA which is ordinarily tightly controlled by methylation. 
Codon usage is another method many organisms use to control gene expression, 
including HPV (94). The eight HPV genes were analysed to determine how similar 
the codons were to those used in mammalian cells, it was found that L2 and L 1 
had the least similarity (94). Mammalian genes generally use a G or C at the 3rd 
position of the codon making them GC rich; HPV codons mainly employ a T at 
the yd position, making the HPV genome AT rich, the highest AT content was 
found in L 1 and L2 genes (94). Changing the codon composition to those used in 
mammalian cells has greatly enhanced expression of L 1 and L2 (20,58). 
Moreover, when cells differentiate codon usage has been shown to alter to those 
more similar to codons used in L 1 and L2, further supporting differentiation-
dependent control of expression (35,93). 
Negative RNA elements found in Ll and L2 genes have also been implicated in 
regulating gene expression (60). Inhibitory RNA elements can form secondary 
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structures that inhibit polymerase-binding and act directly on the polymerase so 
inhibiting its functioning or possibly sequestering regulatory transcriptional factors 
(60). One RNA element has been described in LI and two have been found in L2 
(60). 
All these regulatory factors coupled together have prevented production of the 
immunogenic L I and L2 in various recombinant systems. Altering of the gene 
codons to those more readily used in mammalian cells has greatly enhanced 
production, possibly acting two-fold in negating negative RNA elements and in 
using more common codons. Overcoming regulation of these genes has allowed a 
greater understanding of their function and lead to the production of VLP-based 
vaccmes. 
1.3 Vaccine: Is L2 a Good Candidate? 
Generation of a vaccine requires the fusion of two seemingly distinct disciplines, 
immunology and microbiology; thus a rudimentary knowledge of immunology is 
needed. A vaccine works by providing an antigen for the immune system so that 
an antibody "memory" is created that will prevent future infection. An immune 
response is developed by the T lymphocytes (T -cells) in the body that constantly 
sample for non-self antigens [for a review see reference (43)] (43,48). T cells do 
so by sampling the peptides bound to the major histocompatibility complex 
(MHC). There are two types of MHCs, MHC I and II, depending on the type of 
cell and the origin of the peptide will determine which MHC a peptide will bind. 
All nucleated cells have MHC I molecules and the peptides they bind are 
generated from endogenous proteins. MHC II molecules are found in professional 
antigen presenting cells (APCs) and are a representation of proteins that originate 
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outside of the cell. In these cells proteins are taken up and degraded in lysosomes 
and kept separate from cellular proteins, so preventing MHC I binding. 
Peptide-MHC complexes are taken to the surface of the cell and presented for 
sampling by the T cells. (see reference (74) for a review with specific emphasis on 
HPV infection). MHC I molecules are sampled by CD8+ cells otherwise known as 
cytotoxic T-Iymphocytes (CTLs) (43). Stimulation of the CTLs leads to marking 
that cell for cell death (under the assumption that it is infected). MHC II molecules 
are sampled by CD4+ cells. When activated CD4+ cells release various cytokines 
to stimulate the immune system. CD4+ cells are further subdivided into two sets of 
helper T cells (Ths), Thl and Th2 (74). The type of infection will determine which 
pathway the non-activated CD4+ cell will undertake which is determined by the 
APC interaction (74). A viral attack or vaccine will induce Th2 cells which will 
produce various cytokines stimulating B lymphocytes (B cells) (74). 
B cells originate III the bone marrow and each contains a specific antigen 
recognition molecule similar to an MHC (74). Once a B cell is stimulated by an 
antigen and with the aid of cytokines from the Th2 cells it begins to divide and 
mature into a plasma cell. Plasma cells produce antibodies, which are a soluble 
form of the antigen recognition molecule. Antibodies will bind the antigen and 
hopefully prevent infection (74). There are two ways in which antibodies can 
prevent viral infection; (i) it can bind to a site in the capsid, inhibiting receptor 
binding; or (ii) bind and inhibit uncoating of the virus (19,25). 
Two vaccines against HPV infection have recently passed rigorous human trials 
and are currently in production, namely, Gardasil and Cervarix which are 
produced by Merck and GSK, respectively. These vaccines exploit the fact that L 1 
expression alone leads to formation of VLPs which have proven highly effective at 
producing a strong immune response that can protect against infection in humans 
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(12,83). The immune response against L1 has been described as type-specific in a 
number of publications (16,21,62,86). The limiting type-specifity of L 1 has been 
overcome by using multivalent vaccines incorporating more than one HPV type in 
the vaccine. Gardasil is a quadrivalent vaccine using VLPs, derived from 
recombinant yeast, with HPV types 16, 18, 6, and 11 and Cervarix a bivalent 
vaccine, derived from recombinant insect cells, incorporating VLPs from HPV -16 
and -18. 
Antibodies raised against VLPs that contain both L 1 and L2 produce a 
predominantly type-specific response compared to the response against the L2 
protein alone (66). This is due to immunodominance patterns that occur. Epitopes 
can be divided into those that produce a strong immune response (dominant 
epitopes) and those producing a weaker response (subdominant epitopes) (81). 
Three major factors that determine the dominance of a peptide are: (i) the antigen 
processing, (ii) the binding affinity to the MHC molecule, and (iii) the stability of 
the peptide-MHC complex (81). The quantity of the antigen has also been 
implicated in MHC I presentation but MHC II appears to be quantity-independent 
(71). It appears that L 1 contains immunodominant epitopes that mask the antibody 
response to the subdominant epitopes found in L2. This could be due to the larger 
amount of L 1 being present and/or may reflect a further viral evolution in 
protecting itself from the immune system. 
A number of epitopes found on the L2 protein (~500 amino acids) have shown 
cross-reactivity. Analysis of the protein sequence of various HPVs has shown 
conserved regions at positions 1-12 and 56-81 (45). The surface regions have been 
characterized at positions 32-51, 69-81, 212-231, 279-291, and 362-381 (Fig. 4) 
(45). Surface regions are the most likely to be targets for neutralizing antibodies, 
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The HPV-16 L2 regiun uf69-S1 was inserkd inlo Ih~ HI'V LI g~ne, tu prudu~c a 
chimeric VLP (cVLP) that displays the epitope on the VLP. Analysis of the 
immune response fuund neutrali..:ing antibodies for bolh HI'V- 16 and H PV -I I 
infedion (73). The region of 108-120 wa.' previously dcscribed as a cross-
neu(rali..:ing ~pitope (461. ho"ev~r. it app'"an; inuculation w;lh lilt: cVLI' with this 
peptide failed to producc ncutralizing antibodies (73), 
A n:c~ptor binding site is another putential region to elidt neutralizing antibodies. 
A possible site was determincJ in Bovine Papilloma\'ims (BPV) L2 in the region 
of I_SS, sequcncc homology was fOllnd in lIPV·16 1.2 to the region 13-31 , and 










Expression of HPY -16 L2 in Plants 
cell-surface binding was later confirmed for this region (66,92). This potential site 
for a neutralizing epitope, however, may be hidden within the capsid and only 
become available upon furin digestion. 
BPV L2 1-88 region was found to elicit an immune response that could neutralize 
a number of HPVs (63). More recently, epitopes HPV-16 L2 1-88, HPV 16 L2 11-
200, Cotton-tail Rabbit Papillomavirus (CRPV) L2 1-88, and CRPV L2 11-200 
were tested (32). The HPV -16 L2 11-200 epitope proved to elicit the best cross-
protection against HPV 16, 18,5,31,45,52,58, and BPV 1. (32) HPV 16 L2 1-88 
epitope was found to elicit a similar response to that of BPV 1 1-88 (32). 
RG-I a monoclonal antibody raised against HPV -16 L2 amino acids 17-36 was 
found to cross-neutralize 16 and 18. This antibody was shown to be able to bind to 
the virion after the initial binding to the cell surface and thereby inhibiting 
internalization (70). Within the 17-36 amino acid sequence of HPV-16 L2 there 
are two cysteine residues at position 22 and 28 and these are highly conserved 
throughout different HPV types. After mutating these cysteines to serines it was 
still possible to obtain infectious virus in organotypic culture, but when both 
cysteines were mutated no infectious virus were obtained indicating the 
importance of these residues (22). In addition, the HPV-16 L2 17-36 peptide was 
fused to a toll-like receptor 2 ligand and a T helper epitope to obtain a lipopeptide. 
Sera from mice vaccinated with the lipopeptide was able to neutralize HPV 16, 18, 
45 and BPVl (3). 
Accumulatively this data indicates that the amino acid region between 17-36 of 
HPV -16 L2 has the potential to be used to raise antibodies that will be able to 
cross neutralize against various HPV types. 










Expression of HPV -16 L2 in Plants 
Peptides in the N-terminal of HPV 16 L2 were also analyzed to determine the 
antigenic regions (51). Using a computer program they determined which would 
be the most antigenic sites, i.e. which peptides are more readily processed by the 
immune system and elicit a cross-protective response (51). The peptide covering 
the region 65 -71 was speculated to be the most immunogenic and produced the 
most cross-protective response, neutralizing HPV 16, 18, 31, and 58 infections 
(51 ). 
1.4 Conclusion 
Various elements in the L2 gene have been shown to be significant in the viral life 
cycle; controlling the expression of a number of genes. The tight control of its own 
expression allows the virus to remain undetected by the immune system. This 
control has also limited expression of L2 in a number of recombinant systems 
which has been overcome by gene codon optimization, increasing its production to 
levels that are easily detectable. Current recombinant technology allows the 
production of L2 in a number of different eukaryotic systems, including; 
mammalian cells, insect cells, and yeast cells. 
The role of L2 in the viral entry is undeniably important, various residues within 
L2 and so present in the virion capsid are necessary for efficient cell entry. Theses 
residues remain attractive sites for neutralizing antibodies to bind; in particular the 
receptor-binding site found in the 17-36 aa region. L2 has also shown a number of 
other potential sites that have cross-neutralizing activity; in particular a site located 
in the surface region that is highly conserved amongst HPV s, the region 56-81. 
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Current information suggests that with expression in a good recombinant system 
the L2 protein, or parts thereof, are an excellent candidate for a cross-protective 
vaccine against HPV and cervical cancer. 
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2. CHAPTER 2 
THE EXPRESSION OF L2 IN PLANTS 
2. 1 Introduction 
The currently available HPV vaccines are projected to cost $120 per dose, making 
the total cost with three doses $360 (1,31). Considering the frequency of infection 
in developing countries and their socio-economic environments, this fee would be 
vastly out of their reach. The patents upon these vaccines will, however, 
eventually expire, leading to a race for alternatively cheaper generic vaccines. 
Plant production of an HPV vaccine may serve this purpose. 
Vaccine production in plants could be cost effective for a number of reasons. First, 
plant systems are more cost effective than the use of fermentation bio-reactors, 
such as those used in bacterial production of heterologous protein (23). Secondly, 
the infrastructure and equipment for large scale plant production and harvesting 
are already in place (23). Thirdly, plants allow for the possibility of an edible 
vaccine, negating purification requirements and needle-associated complications 
(23). Last, the yield from plants has crossed the threshold to industrial levels, 
making their use economically viable (23). These factors have lead to a flurry of 
novel vaccines and pharmaceutical products being produced in plants. 
The vast range of plant-based products is testament to the versatility the system 
endows. Edible vaccines currently being tested include protection against human 
infection by hepatitis B (77), animal infection by rotavirus (88), bacterial infection 
of humans by Shigella (87) and bioterrorism using the anthrax toxin (52). In 
addition. plant production has found a specialized niche in the production of 
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antibodies (11,23,33,49). Various mechanisms are employed to produce a protein 
in plants, including chloroplast transformation involving the transformation of the 
chloroplast genome as opposed to the nuclear plant genome. A number of 
advantages of this method have been argued, in particular the means of bio-
containment of the foreign gene (23,47). 
Transgenic plant lines, however, remam at present the predominant means of 
producing heterologous gene products in plants. Recently an alternative system, 
namely transient expression, has gathered interest. This involves the infiltration of 
plant material with acetosyringone-induced Agrobacterium containing the plasmid 
with the foreign gene. Acetosyringone is a plant phenolic that activates the vir 
genes on the tumour-inducing plasmid within Agrobacterium which facilitates the 
relocation of the transfer DNA (T-DNA) from the bacterium to the plant cell. A 
single strand copy of T-DNA (ssDNA) is transferred and localized to the nucleus 
of the plant cell (95). The ssDNA is made double-stranded at which point it can be 
used by the cell for transcription, a fact exploited by the transient expression 
system (95). 
The T-DNA can stably integrate into the plant chromosome or, what is more often 
the case, remain in the nucleus as extrachromosomal DNA (95). Integration leads 
to the ability to make transgenic lines. One advantage of transient expression is 
that expression can be determined shortly after DNA delivery as compared to 
transgenic plant regeneration, which requires a number of months. In addition, 
gene silencing due to positional effect of integration, commonly seen in 
transgenics, is negated. 
A number of vectors have been designed to facilitate the transfer of the T-DNA. 
Binary vectors are commonly used; however, various novel vectors have been 
designed to remove the cumbersome system of ensuring both plasmids are present. 
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Such an example is the pTRA vectors which have the necessary genes for 
selection of the recombinant bacteria and the foreign gene on one plasmid. The vir 
genes are contained within a stable helper plasmid found in the specific GV31 0 I 
Agrobacterium. These and other vectors have contributed to the increase in 
expression levels available in plant systems. Expression of foreign genes, 
however, can be limited by the natural defence mechanisms of the plant. 
Transient expression has been characterized by limited levels of the gene product 
after a number of days due to post transcriptional gene silencing (PTGS) (75,84). 
Heterologous gene expression is often under the control of a strong, constitutive 
promoter leading to a large number of mRNAs being present in the plant cell. A 
certain amount of inter- and intra-molecular homology in the RNA will be present 
within these sequences which will associate and dissociate relative to the 
concentration of the mRNA in the cell. Any dsRNA present in the plant cell is 
recognized by an RNAse III-like protein that will cleave dsRNA into 21-25 bp 
short interfering RNAs (siRNAs) (84). An siRNA associates with a nuclease -
giving the nuclease sequence specificity - which will in tum go on to degrade any 
RNA with sequence homology (Fig. I) (84). A number of plant viruses have 
developed methods of avoiding the host defense by encoding proteins that 
interfere at various stages of the mechanism. 
















~'ig"rt l. Ui~grammati'· ,·it .. · uf I'TGS. E\ogcnuus mRNII i, made irum the T_DNA. Tl""e 
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of a gene to those more commonly used in plants, gene expreSSIOn should, in 
theory, increase. 
With these principles in mind this chapter reports on investigations aimed at 
establishing whether the L2 protein, like its counterpart L 1, can be efficiently 
expressed in plants. If so, to determine which L2 gene would produce the highest 
yields, i.e. the wildtype, one whose codons have been optimized for plant 
expression or one which has been optimized for mammalian expression? And if 
one gene is found to produce greater amounts of L2 we sought to investigate why 
this would be so. In addition, once expression is established it would be interesting 
to determine where in the plant the L2 is targeted and whether specific targeting to 
different cell compartments would yield different amounts. Finally, this study 
further seeks to determine if full VLPs that incorporate L2 can be produced upon 
simultaneous transfection, with a view of making a cheaper vaccine for developing 
countries. 
2.2 Methods 
2.2.1 Plasmid Construction 
Agrobacterium vectors pTRAc, pTRAkc-A, pTRAkc-ERH and pTRAkc-rbcsl-
cTP were supplied by Rainer Fischer (Fraunhofer Institute for Molecular Biology 
and Applied Ecology IME, Aachen, Germany) (Fig. 2). 
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Figurt' 2. Agr"b",-/rri"", "eetur> utitb,:d in thi, 'h"l~'_ Th~y ~rc pTRAc (A). pTRAkc-l\ (R). 
pTKAke-ERH (C). ~nJ pTRAk~-rtx;'l-~TP (ll). The light bl l'" bar inJicate, tlw l-llNA lh~l i, 
tran,ferred to the plaJlt cell at transtectiol1. The hetemlugom gene is cloned into the vector, at the 
nUllt iple clol1 in g site (MCS). The vectur, share a ""mher of cummon fcatllre, indicated by 
rcgiu ns in grcy . The T-DNA regiun is n~nkd by thc kfllxlf(,\cr(LB) 310 tlw righl lwd", (RR). 
At cithcr ~rld 0 f tlw MCS are sc~ffuld 31lacluocrK regiu ns (SAR). F~rrcssiu n uj' lile tr~ fl sg~nc is 
eunlwllcd by ~ du~l 35S C~uli tlu "'''' Mu,~ic Virus I"urouter (P35SS C~MV) "'ilh 3lWChrr><:nl uf 
the jXllyadenylation , igna l oj'the ' aJ11e Ca,\-IV gel1e (pA3'S). Rep li cation of the vector in 
AR'''''"creriJiln is il1 it iated at the RK2 ori. A "'parale repli cation mitiation , itc, ColFL is used ill 
1':. ,-,,,Ii. The pTRAc vec lur cunt~ins un Iy ()I);;: ~ntibiulic rcsist~nc~ m3f~cr (bit<) ~ Ilu" i ng: Sd""l ilWl 
" i,h ~rTlpicillit\lk~n~rTlycin_ The rTRA ke-A. pTRAke-ERH ~nJ pTRAkc-rocsl-cTP WJ1l~ifl a 
,~cu nd ~tll ibiolic JJl~rJ...cr ("1'111) perrnilling: ",lectiol1 with bl1amy~in ill planK l1,e nplff gerl<' is 
C(~ltf(~led by the promoter of the A,i'nbacl~ri"'n ge l1e l10paline symhase (Pn<b), the 
lX'Iyadenylat iol1 oftl'" ,aJl", ger'" i, anach(X! to nptll (pAr",,). pTRAkc.A ha, a secrCTory signal 
(I.PJT) im n",diaTcl)' uf'STrc"m of the MCS, pTRAkc·ERH ~ I ",-l IUb tl'" LPH ,i gn~l ~ rl.l 
add i t i Ol\~ ll y in dlKles ~ His l~g (His6) s"<locrlCe ~nd ~n cndo.lpla,mi~ r(1ic u]um r~lenlion sign ,,1 
(K [)EL) SC\l u~rlCC do,,'n'lre~rTI uj'lhe \1CS, p'l RAke-rb..;, I-e II' illl' l uJ~, a chioropiasl signalli fig 
peplide (rbe, l-cT!') seqoorlCe lV'trem11 uf the ,\-Ies, 
The pTKA vectors hold a numher of characteristics that optimi7.e the expression of 
the foreigl1 gene. p I"KAe contains the skeicton features aud is prolicient at 
transgene expre"ion in the c)toplasm of plal1t cells (Fig. 1). The other ~eclOJ1l 
prKAkc-A, pTRAke-ERH and pTRAh-rbcsl-\.TP indude addilionu l sequences 
for Ihe largeting of the transgene expression to the apoplastic spa.:e, ~--ndoplasmic 
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reticulum (ER) and chloroplast, respectively. The left and right borders flank the 
region of DNA that will be transferred to the plant cell, the T-DNA. The scaffold 
attachment regions, also known as matrix attachment regions, are on either side of 
the transgene. These regions are thought to interact with nuclear matrix proteins 
forming loop domains in DNA which has been shown to increase expression with 
insertion in a plasmid (59). 
Expression of the transgene is controlled by a dual P35S CaMV promoter, with a 
duplicated transcriptional enhancer. This promoter has been shown to increase 
expression over the traditional single P35S CaMV (67). The polyadenylation 
signal of the P35S gene is fused to the end of the foreign gene; this stabilizes RNA 
transcripts. Replication of the plasmid in Agrobacterium is initiated at the RK2 
origin of replication. Due to the low copy number of the plasmid in 
Agrobacterium, the vector can alternatively be replicated in Escherichia coli using 
the ColEl origin of replication (50). The development of resistance by a number 
of Agrobacterium to ampicillin has lead to the fusion of kanamycin and ampicillin 
resistance in the bla gene. Ampicillin is used as a marker in E. coli with 
kanamycin as a marker in Agrobacterium. 
Three different L2 genes were used (i) the wildtype HPV-l6 L2, (ii) the HPV-l6 
L2 codon optimized for expression in plants (plantized) and (iii) the HPV-l6 L2 
codon optimized for expression in mammalian cells (humanized). Codon 
optimization for the plantized gene was performed by GENEART® (Regensberg, 
Germany) to be optimized for Nicotiana. The humanised gene was generously 
supplied by Martin Muller (Deutsche Krebsforschungszentrum, Heidelberg, 
Germany). Restriction enzyme sites were included at either end of the L2 open 
reading frame (ORP) by polymerase chain reaction (PCR) to facilitate the 
directional cloning into the vectors. 
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Cloning into the pTRA-C vector requires the gene to be placed in frame on the 
plasmid and so BspHI is necessary as it contains an A TG site within its restriction 
site. The downstream restriction enzyme may vary. The wildtype L2 ORF (saL2) 
was amplified with the primer pair F saL2-pTRAc and R saL2-pTRAc (Table 1). 
The primer pair F pL2-pTRAc and R pL2-pTRAc were used to amplify the 
plantized L2 ORF (pL2). With the humanised L2 ORF (hL2) the primer pair of F 
hL2-pTRAc and R hL2-pTRAc was used. The 1.4 kb fragments were cloned into 
® pGEM -T easy (PROMEGA) and sequenced to confirm PCR fidelity. The saL2 
was excised with restriction enzymes BspHI and XbaI and subcloned into the 
AflIII and XbaI sites of pTRAc making the plasmid pTRA-saL2-C (Table 2). 
Restriction enzymes BspHI and BamHI were used to excise pL2 which was 
subsequently subcloned into the AflIII and BamHI sites of pTRAc making the 
plasmid pTRA-pL2-C. Finally, restriction enzymes BspHI and XbaI were used to 
excise hL2 and subcloned into the AflIII and XbaI sites of pTRAc making the 
plasmid pTRA-hL2-C. 
Similarly the three genes were subcloned into the pTRAkc-ERH vector. The in 
frame placement of the gene using BspHI in this vector becomes important due to 
the addition of the secretory signal, LPH. The same forward primers and so 
corresponding restriction sites, used to clone the genes into the pTRAc vector were 
utilised (Table 1). Due to the requirement of a translational fusion at the C-
terminal the stop codons of the ORFs were mutated and replaced by a Not! site. 
The addition of a his6 tag allows for purification and the KDEL sequence 
facilitates retention of the protein in the ER. Primers R saL2-ERH, R pL2-ERH 
and R hL2-ERH (Table 1) were used to subclone saL2, pL2 and hL2 into the 
pTRAkc-ERH vector making the plasmids pTRA-saL2-E, pTRA-pL2-E and 
pTRA-hL2-E, respectively (Table 2). In addition, a fourth plasmid was made with 
the hL2 gene that incorporated the hL2 fragment from the pTRAc clone into the 
pTRA-kc-ERH vector which resulted in removal of the translational fusion 
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making the plusmid pTRA-hL2-A (Tuble 2), Thus. the prOlt:in would not bt: 
Tt:tur(kd in tht: ER dut: to tht: ab~~nc~ of the K DEL ~equence and is allow~d to he 
seereted_ 
Concurrently the three genes wt:re sulx: lont:d into the pTRAkc-rhcsl-cTI' vector 
which also rt:quires a translational fusion of a ehlomp l as1-\arg~ting domain at \he 
N-terminal. ror this reason a longer lorward primer is required thut iJ](:orpomtes u 
Milli sill: into Ih~ l'ragmt:nt. l'rimt:rs f saL2-CTl'. f pL2-CTI' and F hL2-CTI' 
(Table I) were used tu subc lone saL2, pL2 and hL2 into the p'l RAke-rbesl-eTP 
\'O;;cloT to mak~ plusmids pTRA-saL2-1'. pTRA-pL2-I' and pTRA-hL2-1'. 
respectively (I 'ab le 2). The eorrc~ponding reverse primer used to elone the 1,2 
g~nt:s into p'l RAe wn~ employed (Table I). 
TMbl~ I ; Prim.',." "S~tI in doning, 
Prim~.· Nam~ Scq uencc 
F'MU.pTR.-\c 
K-soU-p IRAe ,"'ATC"! AG AfT _\ G(~C"'(~CC-\AA(~-,H~"'C 
R·,al ,2·ER H AA(;C(;GCCGCGGC\GCCAA.~GAG ,\CA'I C 
F·,.U·(TP ,\AACGCGI 1 ,\GG IG CATGAG ,\CAC\ ,\ACGTICTGCAAAAC 
F.pL2.pTRAc A,-\'I C \ I (, '>'GM"'>'T '>',o.{;'>'GAIC! GC 1 \.~G 
R-pL2-pTRAc CC(;(;A 'W f"(-r AAGCAGC,>. ,>.G\(; ,U,\(:,-\ TC 
F-pL2-lTP CCM'CCG rTAGCT(;C HCAGM:,>. I'A,>.GAG,>.'1 (TGC 
F-hL2-p I"RAe A1TC AT(. AGGC .. CAAG ... GC. ... GCCCC 
K-hL2-r I fl.-'Ic ATICT"'G A TC _\ GCCGCCCACGCTC ... C 
K-h L2-LIl.I I AH~CCGCCCCCCCCCCC ,>.GCCTC\CCTC 
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Table 2: Agrobacterium clones that were used. 
Plasmid Name Insert 
Agrobacterium Agrobacterium Cell Compartment 
Strain Vector Targeted 
pTRA-saL2-C HPY-16 saL2 GY3101 pTRAc cytoplasm 
pTRA-saL2-E HPY-16 saL2 GY3101 pTRAkc-ERH endoplasmic reticulum 
pTRA-saL2-P HPY-16 saL2 GY3101 pTRAkc-rbcs l-cTP chloroplast 
pTRA-pL2-C HPY-16 pL2 GY3101 pTRAc cytoplasm 
pTRA-pL2-P HPY-16 pL2 GY3101 pTRAkc-rbcs l-cTP chloroplast 
pTRA-hL2-C HPY-16 hL2 GY3101 pTRAc cytoplasm 
pTRA-hL2-E HPY-16 hL2 GY3101 pTRAkc-ERH endoplasmic reticulum 
pTRA-hL2-P HPY-16 hL2 GY3101 pTRAkc-rbcs l-cTP chloroplast 
pTRA-hL2-A HPY-16 hL2 GY3101 pTRAkc-A apoplastic space 
'pTRA-hLl-C HPY-16 hLl GY3101 pTRAc cytoplasm 
'pTRA-hLl-P HPY-16 hLl GY3101 pTRAkc-rbcs l-cTP chloroplast 
• pTRA-GFP-P GFP GY3101 pTRAkc-rbcs l-cTP chloroplast 
'pTRA-p19-C pl9 GY3101 pTRAc cytoplasm 
~pBIN-NSs NSs LBA 4404 pBIN cytoplasm 
'Clones were supplied by James Maclean, this laboratory. 
#Clone provided by Marcel Prins, Wageningen Agricultural University. 
2.2.2 Generation of Recombinant Agrobacterium 
Agrobacterium tumefaciens GV31 0 1 was provided by Rainer Fischer (Fraunhofer 
Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany). 
The GV31 0 1 strain contains the helper plasmid, pMP90RK, which contains the 
crucial vir genes (50). The pTRA vectors can be replicated in E. coli as well as 
Agrobacterium. The vector constructs were initially cloned into DH5a cells, which 
are easier to culture and have a higher copy number of the plasmid in comparison 
with Agrobacterium (50). Plasmid DNA was isolated from DH5a cells and the 
concentration was determined by UV spectrometry at 260 nm. 
GV31 0 1 cells were grown to log phase at 0.8 OD600 at 26°C with shaking in Luria 
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(30/lg/ml). Cells were subsequently made electrocompetent by washing three 
times with Milli-Q water and resuspended in 1120 the culture volume in 10% 
glycerol to allow for storage at -20°e. 
Plasmid DNA (400 ng) isolated from DH5a was mixed with 100 /ll of 
electrocompetent GV31 a 1 cells III a 0.1 cm cuvette (BIORAD@) and 
electroporated using the following parameters; 2000, 25 /IF and 1.5 kV (Gene 
Pulse, BIORAD®). After incubation at 26°C in LB for one hour the electroporated 
cells were placed on Luria agar (LA) containing rifampicin (50 /lg/ml), kanamycin 
(30 /lg/ml) and carbenicillin (50 /lg/ml) and allowed to grow at 26°C for 3-4 days. 
Successful transformation was determined by colony PCR or restriction enzyme 
analysis. Due to the low copy number in Agrobacterium, the plasmid was 
transformed into DH5a for restriction analysis. 
Glycerol stocks of the suitable Agrobacterium clones were made. This resulted in 
a total of ten clones being made (Table 2). In addition, Marcel Prins (Laboratory 
of Virology, Wageningen University, Wageningen, Netherlands) provided the 
Agrobacterium recombinant with the pBin-NSs plasmid coding for the NSs 
protein (Table 2). James Maclean provided the Agrobacterium GV3101 clones 
with plasmids pTRA-hLI-C and pTRA-p19-C that code for the humanised Ll and 
p 19 proteins, respectively (Table 2). 
2.2.3 Plant Lines 
Wild type Nicotiana benthamiana and Nicotiana tabacum cv Petite Havana were 
used and grown under conditions of 16h light and 8h dark at 22°e. Plants were 
utilised 14-28 days after being transplanted from seedling trays to pots. 
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2.2.4 Preparation of Agrobacterium for Infiltration 
The infiltration protocol simulates the natural process of Agrobacterium induction 
by acetosyringone. The induction and infiltration medium both contain varying 
amounts of acetosyringone which activates the different vir genes according to 
concentration (95). Clones were grown from glycerol stocks in LB with rifampicin 
(50 Ilg/ml), kanamycin (30 Ilg/ml) and carbenicillin (50 Ilg/ml) to an OD6oo 
between 1 and 2 at 26°C. Agrobacterium was centrifuged at 5,000xg for 10 min at 
room temperature (RT) and resuspended in induction medium [LB, 10 mM MES, 
2 mM MgS04, 20 11M acetosyringone, rifampicin (50 Ilg/ml), kanamycin (30 
Ilg/ml) and carbenicillin (50 Ilg/ml) at pH 5.6] and grown to an OD600 of 1-2 at 
26°C. Cells were centrifuged at 5,000xg for 10 min at RT and resuspended in 
infiltration media (10 mM MES, 10 mM MgClz, 2.2105 gil Murashige Skoog 
salts, 35 gil sucrose, 150 11M acetosyringone at pH 5.6). The optical density of the 
cells were measured and diluted in infiltration media to an OD of 0.4-1. Cells were 
incubated for a minimum of 3h in the infiltration medium before infiltration. 
2.2.5 Infiltration Procedure 
Two different infiltration protocols were used; injection infiltration or infiltration 
under vacuum. The injection procedure requires a 1 ml syringe which is used to 
inject the Agrobacterium suspended in infiltration media directly into the abaxial 
air spaces of the plant leaves. 
Vacuum infiltration required uprooting of the whole plant and suspending them in 
infiltration medium containing the Agrobacterium clone. This was placed under 
vacuum at 80 mbar for 5 min. Upon release of the vacuum the air spaces in the 
leaves were infiltrated and the plant was replanted. Plants were subsequently 
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covered in cellophane bags for 2 days, or longer, and incubated at 28°C in a 
humidity-controlled room. Vaquero et al. (1999) used an alternative method of 
using just the leaves not the whole plant; we modified that protocol for our own 
purposes. 
2.2.6 GFP Imaging 
As an easily traceable protein product which can be readily visualized, GFP was 
used to determine the progress of protein expression within the transient 
expression system. Two week old N. benthamiana plants were infiltrated with the 
Agrobacterium clone containing plasmid pTRA-GFP-C. Leaves were measured on 
a short wave UV light box (Gene genius Bio imaging systems, Syngene - a 
division of SYNOPTICS LTD.) after six days with the light source from below. 
Photos were adjusted using Adobe Photoshop Elements 2.0. 
2.2.7 Protein Extraction and Western Blots 
To determine whether expression was present within the plant standard techniques 
of SDS-PAGE and western blot analysis were used. The size of the sample 
determined the method of homogenization: if it was below SOO mg fresh weight 
eppendorf pestles were used and if above SOO mg the leaf tissue was frozen in 
liquid nitrogen and ground in a mortar and pestle. Homogenized sample was 
suspended in 2 Ill.mg-1 of buffer. Buffers used were either PBS at pH 6.7, high salt 
PBS (O.SM NaCI) or 8M urea. Cell debris and other larger molecules were 
separated either by a mesh filter, if the samples were large enough, and/or 
underwent 2 centrifugation rounds (lO,OOOxg, 10 min at RT). 
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SDS-PAGE loading buffer was added to the samples and boiled for 10 min. 
Sample was then loaded onto a 10% SDS-PAGE and run at 20mA/gel for -2.5h. 
Protein was transferred to nylon membrane (Nitrobind, Cast, Pure nitrocellulose, 
0.45 micron, OSMONICS INC.) by semi-dry blotting at 15V and 400 rnA for 2h 
(Trans BlotE' semi-dry, BIORAD® with the power supply Electrophoresis Power 
Supply, AMERSHAM®). The success of the transfer was measured by coomassie 
blue staining of the gel after transfer. 
The membrane was blocked OIN in PBS (5% skimmed milk, 0.05% Tween-20). 
The membrane was then incubated for 2h at RT with the primary antibody 
followed by 4 repeated washes in PBS (5% skimmed milk, 0.05% Tween-20). For 
detection of L2 rabbit polyclonal serum was used at 1: 1 ,000 and for L 1 mouse 
monoclonal antibody (14) was used at 1 :3,000; diluted in PBS (5% skimmed milk, 
0.05% Tween-20). Subsequently, the secondary antibody was diluted in PBS (5% 
skimmed milk, 0.05% Tween-20) and added to the membrane and incubated at RT 
for lh followed by 4 repeated washes over Ih in PBS (0.05% Tween-20). 
Antibodies goat-lX-rabbit and goat-lX-mouse conjugated with alkaline phosphatase 
(SIGMA ®-Aldrich) were used as secondary antibodies for L2 and L1, respectively; 
both were diluted to 1: 10,000. Immunodetection was done using 5-Bromo-4-
Chloro-3-indolyl phosphatelNitroblue tetrazolium (BCIPINBT) made according to 
manufacturer's instructions (ROCHE® Diagnostics). 
2.2.8 Enzyme Linked Immunosorbent Assay (ELISA) 
In an attempt to quantitate the expression of L2 and hopefully detect expression 
unable to be seen with a western blot the more sensitive ELISA was employed. 
Detection ofHPV-16 L2 was done by coating a Polysorb® 96-well plate (NUNC®) 
with L2 samples either in PBS or 8M urea OIN at 4°C. Plates were blocked in PBS 
with 5% skimmed milk for 1h. Non-specific binding was determined by coating 










Expression of HPV -16 L2 in Plants 
wells with only PBS or 8M urea. The plate was incubated with rabbit polyclonal 
antiserum raised against HPV -16 L2 (1: 1 ,000) for 3h followed by 4 repeated 
washes in PBS (5% skimmed milk, 0.05% Tween-20). Plates were then incubated 
with goat-a-rabbit antibody conjugated with alkaline phosphatase (SIGMA ®-
Aldrich) diluted (l :5,000) in PBS (5% skimmed milk) for 1.5h. The extinction was 
measured at 405 nm at 30 min after adding the substrate Sigma F ASTTM p-
Nitrophenyl Phosphate (pNPP) made as per manufacturer's instructions 
(SIGMA ®-Aldrich). The extinction coefficient was measured on the Multiskan® 
PLUS, Titrek:B:. 
2.2.9 Concentrating the L2 Protein 
2.2.9.1 Tri-Chloro Acetic Acid (TCA) Precipitation 
TCA precipitation is a commonly used technique to concentrate proteins. It acts to 
precipitate all soluble proteins which may then be pelleted and thus allow 
resuspension in a smaller volume. Sample was extracted from leaf material as per 
the extraction method for material >500mg. 112.5/l1 of 50% TCA was added per 
lml of sample. The protein was pelleted by centrifugation at 13,OOOxg for 8 min. 
The pellet was washed twice, first with acetone containing 20mM HCI and then 
with acetone alone after each wash the sample was centrifuged at 13,OOOxg for 8 
min. The pellet was then dried for 10 min subsequently broken apart and 
resuspended in 25 mM Tris (2% SDS) at 4°C OIN with shaking. The pellet was 
resuspended in a tenth of the original starting volume resulting in a la-fold 
concentration. 
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2.2.9.2 Chloroplast Isolation 
Due to the targeting of the protein facilitated by the pTRAkc-rbcs l-cTP vector it 
was thought that by specifically isolating the chloroplasts and then resuspending 
them in a lower volume that an increase in concentration may make it possible to 
visualize the protein on a western. The clones with plasmids pTRA-saL2-P, 
pTRA-pL2-P and pTRA-hL2-P were used to infiltrate plants. Chloroplasts were 
isolated from infiltrated plant material using the Chloroplast Isolation Kit from 
SIGMA E-Aldrich as per manufacturer's instructions. Chloroplasts were either 
lyzed in SDS-PAGE loading buffer or lyzed and butanol extracted to remove 
chlorophyll. Subsequently samples were run on a western. 
2.2.9.3 His-tag purification 
The clones with plasmids pTRA-saL2-E and pTRA-pL2-E express the L2 protein 
fused to a His tag. It was thought that by isolating the His tagged proteins and 
resuspending them in a lower volume that an increase in concentration may allow 
detection. Extracted leaf sample was used in conjunction with the MagneHisTM 
protein purification kit (PROMEGA ®) which uses the principle that His-tagged 
proteins bind to Nickel (Ni) particles and the Ni-particles can be magnetically 
separated out of solution. Once separated the protein is removed from the Ni 
particles by competitive binding of imidazole. The manufacturer's protocol is 
specific for microbial isolation thus it was modified to be used in plants. Plant 
material was extracted in Wash Buffer solution under denaturing conditions and 
the manufacturer's protocol followed. 
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2.2.10 RNA Extraction 
RNA is notoriously difficult to extract mainly due to the abundance of RNAses in 
the environment, for this reason immense care needs to be taken. Two-week old N. 
benthamiana plants were injection infiltrated with Agrobacterium clones 
containing the plasmids pTRA-hL2-P, pTRA-saL2-P and pTRA-pL2-P. Total 
RNA was extracted from the plants at six days post infiltration using the RNeasy® 
Plant Mini Kit (Qiagen). The protocol was followed according to the manufacturer 
using the RL T buffer and included a DNase step. RNA was quantified using UV 
spectrometry at 260nm. RNA was subsequently either stored at -70°C or 
immediately transcribed into cDNA. 
2.2.11 cDNA Synthesis 
As mentioned RNA is considered highly unstable making long term storage 
difficult and risky, for this reason the mRNA was converted to cDNA which is 
easier to store and less susceptible to degradation. The mRNA was transcribed into 
cDNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche® Applied 
Science). The protocol was followed per manufacturer specifications utilizing the 
supplied anchored-oligo( dT) 18 primer. Due to the addition of the Poly A tail on all 
mRNAs to enhance stability this primer ensures only the mRNA is transcribed. 
The cDNA was subsequently stored at -70°C or immediately used for real time 
PCR. 
2.2.12 Real Time peR 
The cDNA was used for real time PCR utilizing the LightCycler® FastStart DNA 
MastelLUS SYBR Green I kit (Roche® Applied Science). The protocol was 
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followed in accordance with those specified by the manufacturer and run using the 
Rotor Gene RG-3000A (Corbett Research). 
All reactions under went an initial pre-incubation step of 95°C for 10 min to 
ensure the cDNA was denatured and activate the FastStart DNA polymerase. 
Thirty run cycles were used for all reactions which comprised of a denaturation 
step followed by an annealing step and finally an extension step. Each reaction 
used the same denaturation step of 95°C for lOs. The hL2 (F-hL2 and R-hL2), 
saL2 (F-saL2 and R-saL2) and pL2 (F-pL2 and R-pL2) real time PCR primers had 
an annealing temperature of 62°C, 54°C and 54°C, respectively, and were allowed 
to anneal for 10s (Table 3). Two housekeeping genes that did not change with 
experimental conditions were chosen to normalize the data. They were 18S and 
Actin-2. 18S (F-18S and R-18S) and Actin-2 (F-Act2 and R-Act2) real time PCR 
primers with annealing temperatures of 54°C and 55°C, respectively, were also 
allowed to anneal for lOs within their respective reactions. All reactions had the 
same extension step of 72°C for lOs. At the end of each run a melt curve was 
assembled between 72°C and 95°C. 
Samples were run in triplicate where possible and a standard curve was generated 
for each batch of reactions using quantified dilutions of DNA from the 
corresponding gene of interest, i.e. dilutions of a known concentration of pTRA-
hL2-P plasmid were run to generate a standard curve when detecting hL2 mRNA. 
Data was analyzed using the Rotor-Gene 6.0.41 software. 
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Table 3: Primers used for RT-PCR 
Primer Name Sequence 
Annealing Size of Amplified 
Temperature Region 
F-hL2 GCAACGACAACAGCATCAAC 
62°C 133 bp 
R-hL2 GTCCTCAGGGTCTGCTTGTT 
F-saL2 TCCCACTTTCACTGACCC 
54°C 221 bp 
R-saL2 TGTTGTGTTGTGCGACTA 
F-pL2 CCAGTTAGACCACCACTTAC 
54°C 252 bp 
R-pL2 GTGGTTGAAGAACAGATGG 
F-1SS GTAAGGATTGACAGACTGAG 
54°C 212 bp 
R-1SS CAGACCTGTTATTGCCTCA 
F-Act2 ATGCCATCTTGCGGTTAG 
55°C lOS bp 
R-Act2 CGATTTCCCGTTCAGCAG 
2.2.13 Arabidopsis Small RNA Project (ASRP) Data Analysis 
The sequences of the various L2 genes were in essence compared by BLAST 
analysis (36) against the database created by the ASRP. By entering the user-
defined sequence the TargetFinder program searches the sequence for potential 
small RNA target sites. Using the parameters: mispair, bulge or gap - 1.0; G:U 
pair - 0.5; with a double penalty if the mispair, bulge, gap or G:U pair occurs 
within the 2 to 13 region relative to the 5' end of the small RNA; and a maximum 
of one single nucleotide bulge or gap allowed. The results are given as predicted 
scores and if this value is equal to or below four it is a plausible small RNA target 
site. The database comprises of 1920 unique small RNA sequences from various 
sources that have been discovered in Arabidopsis (36). 
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2.2.14 Preparation of Plant Material for Electron Microscopy 
One of the pnmary concerns with electron mIcroscopy IS preservation of the 
sample material such that what is seen is a true reflection of what is happening in 
vivo. Two week old N. benthamiana plants were infiltrated with Agrobacterium 
clones with plasmids pTRA-hL2-A, pTRA-hL2-C, pTRA-hL2-E and pTRA-hL2-
P. As a negative control plant material that had not been infiltrated was used. 
Leaves were cut into strips after six days and immediately fixed overnight in 2.5% 
gluteraldehyde made in 0.1 M PBS and containing 0.5% caffeine. The samples 
were then washed three times in 0.1 M PBS followed by a dehydration sequence. 
The sequence consisted of 2 x 5 min in 30% ethanol, 2 x 5 min in 50% ethanol, 2 x 
5 min in 70% ethanol, 2 x 5 min in 90% ethanol, 2 x 5 min in 95% ethanol and 
finally 2 x 10 min in 100% ethanol. The samples were then gradually impregnated 
with LR white resin before placing them in pure resin in beem capsules and 
allowing it to set at 60°C for 16 hours. 
Knives were made from glass and used in the microtome to section the samples. 
Two thicknesses of sections were made, 120 nm and 90 nm, with the finding that 
90 nm sections were ideal for our purposes. Ribbons of section were placed on 
nickel grids that had been coated with butivar. Butivar serves to create a scaffold 
in between the spaces of the grid to reinforce the thin, fragile sections. 
Grids were then blocked with a PBST solution with 5% skim milk for 30 min. The 
primary antibody (polyclonal rabbit aL2 antibody) was then allowed bind at a 
dilution of 1 :300 in PBST with 5% skim milk at 4°C overnight. Grids were then 
washed 20 times in PBST with 5% skim milk followed by binding of the 
secondary antibody (monoclonal goat oRabbit antibody conjugated with 10 nm 
gold particles) at a dilution of 1:50 in PBST with 5% skim milk at room 
temperature for 60 min. Grids were later washed five times in PBST and then 










Expression of HPV -16 L2 in Plants 
fixed in 1 % gluteraldehyde in PBS for 5 min. This second fixation step ensures the 
target - 1 ° Ab - 2° Ab complex is preserved throughout the subsequent staining. 
Uranyl acetate and lead citrate staining was used. First, the grids were stained with 
uranyl acetate for 10 min; then washed five times with water. Then stained with 
lead citrate for 10 min and finally washed 40 times with water. Grids were allowed 
to dry and then used for electron microscopy. 
2.2.15 Electron Microscopy 
Grids with plant sample were visualized usmg the lEOL 200CX transmission 
electron microscope available at the Electron Microscope Unit of UCT. 
2.2.16 Butanol Extraction 
Butanol extraction serves to remove various plant compounds that may interfere 
with later applications such as polyphenols and chlorophyll. For this reason it was 
used in the purification of VLPs and in chloroplast isolation. Leaves were 
macerated in high salt PBS buffer in a Woring blender and homogenized using a 
Silverston homogenizer. Tween-80 (final 0.05%) was added to solubilize L2 and 
to remove proteins that are loosely attached to membranes. The solution was 
subsequently put through a vinyl mesh to remove large debris. Butanol was added 
to the filtrate at a ratio of 1: 1 and left to separate into the aqueous and non-polar 
phase. The aqueous phase should contain all soluble protein and was subsequently 
removed for analysis. 
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2.2.17 VLP Purification 
2.2.17.1 High Salt PBS Buffer 
A specific buffer was used in the extraction of VLPs. This buffer contained 0.2 M 
- 0.5 M PBS with the concentration varying in accordance with the amount of 
plant material i.e. a higher concentration was needed with more plant material in a 
lower volume. In addition, 0.1 M NaCl was added which increases the ionic 
strength and was found to maintain the integrity of the VLPs. 2% PVPP (mass to 
volume) was also added which acts on polyphenols to prevent them from being 
oxidized to quinones which releases free radicals and so damages other proteins. 
0.1 M sodium metabisulphate was added to inhibit proteases by chelating metal 
ions and preventing oxidases from releasing free radicals. Finally 0.01 % sodium 
azide was added to remove any bacteria and fungi. 
2.2.17.2 Differential Centrifugation 
Differential centrifugation was used to isolate VLPs capitalizing on the fact that 
they are denser than single molecule proteins. First, leaf material either derived 
from physical extraction or butanol extraction was subjected to a low speed spin at 
3,800xg. The supernatant was removed and spun for 4h at 28,000 rpm. The pellet 
was resuspended in buffer and the supernatant kept for analysis. At this stage the 
VLPs are presumed to be present in the pellet whilst single molecule proteins 
remain in the supernatant. 










Expression of HPV -16 L2 in Plants 
2.2.17.3 Sucrose Gradient Fractionation 
Sucrose gradient fractionation was further used to purify VLPs. Either the pellet 
from the differential centrifugation or sample directly extracted was used. The 
method behind this technique is to create a density gradient using sucrose and then 
load the sample on top of the gradient and allow it to "run" through the gradient. 
In principle, the higher density structures should migrate quicker through the 
gradient whilst the less dense molecules remain closer to the top of the gradient. In 
this way it allows separation of the denser VLP structure from the less dense 
single protein. The pellet from the VLP isolation was thus loaded on a 5-50% 
sucrose gradient and spun at 37,000 rpm for 4h. Fractions were taken and 
analyzed. 
2.2.17.4 Immunoprecipitation 
Immunoprecipitation was another method used to try and isolate VLPs. Guinea 
pig-derived a-Ll antibody (1:50) was mixed with extracted leaf material. Protein 
A conjugated to agarose beads (SIGMA ®-Aldrich) was subsequently added and 
centrifuged to pellet the beads. The supernatant was removed and the pellet, 
directly run on a western. 
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2.3 Results 
2.3.1 A silencing suppressor was used in infiltration. 
In this system, GFP-imaging was used to determine if a silencing pattern was 
present. GFP expression was used as it is an easily observable positive control for 
the infiltration procedure. Two week old N. benthamiana plants were infiltrated 
with the Agrobacterium GV3101 strain containing GFP (pTRA-GFP-P) alone or 
co-infiltrated with Agrobacterium LBA4404 coding for NSs (pBIN-NSs). GFP 
was visualized in infiltrated leaves at 2, 6, and 10 days post infiltration (dpi) under 
UV light. 
At 2 dpi the GFP expression was similar whether NSs was present or not (Fig. 3). 
At 6 dpi there was an apparent difference in fluorescence with the GFP co-
infiltrated with NSs having noticeably more expression. A marked difference in 
expression can be seen at 10 dpi between GFP infiltrated alone and GFP co-
infiltrated with NSs, with significantly more fluorescence when co-infiltrated. 
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2.3.2 Comparison of L2 protein expression in plants when coded 
for by the wildtype and plant-optimized gene. 
Expression of L I in plants was very low when coded for by the wild type gene and 
a plant-optimized (plantized) version of the gene (6). We sought to determine if a 
similar phenomenon occurs with respect to L2 protein expression when coded by 
the wildtype gene (saL2) and a plantized version (pL2) thereof. 
Agrobacterium clones were made that contain the L2 wildtype or L2 plantized 
gene in each of the various pTRA vectors. These vectors differ to each other in 
that each attaches a targeting signal to the protein which directs it to various 
compartments in the cell. The pTRAc vector (clones represented as pTRA-"gene"-
C) attaches no signal to the protein and thus as a default the protein is presumed to 
be targeted to the cytoplasm. The pTRAkc-ERH vector (clones represented as 
pTRA-"gene"-E) attaches a secretory signal to the N-terminus of the protein and a 
KDEL sequence to the C-terminus which are presumed to target the protein along 
the secretory pathway and retain the protein within the endoplasmic reticulum 
(ER), respectively. The pTRAkc-rbcs l-cTP vector (clones represented as pTRA-
"gene"-P) attaches a chloroplast-targeting signal to the N-terminus of the gene that 
facilitates targeting to the chloroplast. 
Clones used included pTRA-saL2-C, pTRA-saL2-E, pTRA-saL2-P, pTRA-pL2-C, 
pTRA-pL2-E, and pTRA-pL2-P. All six of these clones were agro-infiltrated into 
N. benthamiana plants and transient expression was measured at various time 
intervals from infiltration. Leaf material was extracted in 8M urea and samples 
were detected using western blot analysis. No L2 signal was detected in any of the 
samples; as a positive control E. coli-expressed L2 (200 ng) was loaded and an L2-
specific ~72 kDa signal was seen in each western (data not shown). 
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We thought L2 expression may be too low to be detected in a western, for this 
reason we used various methods to determine if any L2 protein was present. The 
ELISA detection method is known to be more sensitive than a western; however, 
an L2 ELISA of the samples produced no meaningful results. The 8M urea could 
play a role in inhibiting detection through ELISA and so different buffers were 
used yet this had no significant effect on detection either. 
A number of concentrating methods were also employed to increase the amount of 
L2 to be detected. These included chloroplast isolation, his-tag purification, and 
TCA-precipitation. No L2 protein was able to be detected in any of the leaf 
samples using either of these methods. 
Thus, it can be confidently concluded that no L2 protein expression in plants is 
present or is able to be detected when coded for by the wildtype gene or a 
plantized version thereof. 
2.3.3 Expression from mammalian codon-optimized L2 in plants. 
Expression of L 1 in plants was found to be best when coded for by the human 
codon-optimized version of the gene (6). Again, we sought to determine if a 
similar phenomenon can be seen in L2 expression in plants. 
Agrobacterium clones were made that contain each of the pTRA vectors each 
containing the mammalian codon-optimized (humanized) L2 gene (hL2). Initial 
determination of expression was done using the pTRA-hL2-C Agrobacterium 
clone which was infiltrated into two-week old N. benthamiana plants. At 5 dpi 
protein was extracted from plant material in 8M urea and expression was 
determined by western blot analysis (Fig 4). A positive control, 200 ng of E. coli-
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expressed L2 protein, was also loaded. A clearly visible band representing the L2 
protein can be seen that was present in the positive control and the plant material 
infiltrated with the Agrobacterium clone containing pTRA-hL2-C but absent in the 
negative control. 
Two methods to quantitate the amount of L2 protein present were employed, 
namely ELISA and western blot analysis. Protein was extracted in 8M urea from 
leaf material infiltrated with the Agrobacterium clone containing plasmid pTRA-
hL2-C at 5dpi. The leaf material was initially weighed prior to extraction with a 
IO-fold and then 2-fold serial dilution of the sample being made ranging from 8mg 
(undiluted) - 0.2 mg (40-fold dilution). An L2 ELISA was attempted on these 
dilutions but, as previously found, the amount of L2 was unable to be determined. 
Again this may be due to the 8M urea buffer being used or possibly interference 
created by other plant proteins. A crude quantitation was completed utilizing 
western blot analysis (Fig. 4). 
The dilutions were electrophoresed and transferred to nylon membrane for 
detection through western blot. The undiluted sample (8 mg), IO-fold dilution (0.8 
mg) and 20-fold dilution (0.4 mg) all produced a detectable protein band for L2 
confirmed by the positive control of 200 ng of E. coli-expressed L2 (Fig. 4). This 
L2 band was absent in the negative control (non-infiltrated plant material) (Fig. 4). 
Upon analysis of the intensity of the band in the positive control and that of the 
undiluted sample it can be speculated that they are roughly equivalent. Thus, it is 
possible to deduce that the amounts of L2 in both are roughly the same, i.e. both 
appear to contain 200 ng of L2 protein. With this in mind it is possible to estimate 
that the amount of L2 is 200 ng per 8mg of plant material or 25mg.kg-1 of plant 
material. This is lower than expression levels of L I which had the highest value of 
533 mg.kg- 1 (54). 
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Ille dala so far indieat~s high L2 protein exprcssion in plants when it is coded for 
by the humanin::d gt'ne, and undctcctablc cxprcssion whcn it i~ eodcd for by eithcr 
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Expression of HPV -16 L2 in Plants 
that accompanies PCR in addition to spectroscopy of fluorophores that fluoresce 
when they interact with DNA. SYBR green is such a fluorophore that intercalates 
with double stranded DNA (dsDNA) and fluoresces when it does so. Thus, it 
becomes possible to determine at what time the dsDNA within a PCR reaction is 
formed. This time point is important in determining the initial concentration of the 
template at the start of the reaction. Therefore by running various standards of 
known concentration simultaneously with the sample of unknown concentration 
and measuring at what time these dsDNA products of the standards are formed it 
becomes possible to construct a standard curve to determine the concentration of 
the unknown. 
Agrobacterium clones containing the pTRA-hL2-P, pTRA-pL2-P and pTRA-
saL2-P plasm ids were infiltrated into two week old N. benthamiana plants. RNA 
was extracted at various time points to determine the optimal time at which to 
harvest the RNA. An incubation period of six days was found to be ideal for our 
purposes. 
RNA samples were first transcribed into cDNA and then run through Real Time 
PCR amplifying mRNA for pL2, saL2 and hL2. All reactions were run 
simultaneously with respective standards of the genes of known concentrations. In 
addition, mRNA from two reference genes, namely I8S and Actin-2, were also 
amplified from the same RNA samples along with their own standards. These two 
reference genes were chosen based on the fact that their levels did not change with 
a change in experimental conditions and may also be termed housekeeping genes. 
The concentrations of pL2, saL2 and hL2 mRNA were calculated using the Rotor-
Gene 6.0.41 software program. Concentrations of the two reference genes in the 
RNA samples were also calculated in the same way. The program measures the 
time points at which the DNA products form both within the unknowns and the 
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standards and constructs a standard curve that best fits both the unknown time 
points and the standard time points. In this way the time points are translated into 
concentrations. This highlights the importance of the standard curve and in this 
study where the unknown time points did not fall within two standard time points 
these results were not considered. 
In addition, a melt curve was constructed for each reaction between 72°C and 
95°C. Fluorescence is detected at incremental increases in temperature, i.e. it is 
measured at 72°C then the temperature is increased to 73°C and measured again. 
As SYBR green only fluoresces when intercalated with dsDNA with an increase in 
temperature so the dsDNA is dissociated into ssDNA at which point the SYBR 
green no longer fluoresces. This allows you to determine what products were 
formed within the PCR reaction by plotting the derivative of fluorescence divided 
by the derivative of temperature (Y-axis) against temperature (X-axis). Thus, 
peaks are formed at the temperature that products dissociated and so served as a 
further stringency parameter to ensure the results were reliable, i.e. if additional 
peaks formed at lower temperatures indicating primer dimers or non-template 
specific product these results were discarded. 
The concentrations of the mRNA of the vanous L2 genes was subsequently 
normalized using the concentrations of each of the reference genes. The amount of 
pL2 mRNA was found to be the lowest using both reference genes and thus was 
used to calculate the relative amounts in comparative analysis. The mean was 
calculated between the normalized data generated from both reference genes and 
found to be in the ratio of 1 : 11.59 : 21.84 for pL2 : saL2 : hL2 (Fig. 5). 
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2.3.5 In silico comparison of siRNA binding to the various L2 
genes. 
It is well established that siRNAs act to limit gene expression and regulate RNA 
amounts through PTGS in plants. This includes regulation of over-expressed viral 
genes and endogenous genes alike. Thus a pool of siRNAs are present within a 
plant cell and are indeed able to move to other cells giving the system immune 
response-type capabilities (89). With this in mind we sought to determine if this 
pool of endogenous siRNAs may help to explain why L2 expression was markedly 
less when coded by the plantized L2 in comparison to the humanized and wildtype 
genes. 
At present there are no databases for small RNAs isolated from Tobacco. 
However, there is a database that has been recently constructed that contains some 
of the characterized small RNAs in Arabidopsis. The sequences of the hL2, saL2 
and pL2 genes were entered as user-defined sequences that were then blasted by 
the TargetFinder program to determine possible small RNA target sites. Results 
are given in predicted scores whereby a value equal to or lower than 4 are 
considered plausible small RNA target sites. Interestingly, pL2 had the highest 
number of hits with eleven small RNAs with a score of 4, four with a score of 3.5 
and one with a score of 3 (Fig. 6). The saL2 and hL2 number of hits were 
comparably similar with saL2 having two hits at a value of 4 and one at a value of 
3.5 (Fig. 6). Whilst hL2 had three hits with a score of 4 and one hit with a score of 
3 (Fig. 6). 
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using the pTRAc vector was less and expression utilizing the pTRAkc-ERH vector 
was barely detectable (54). These vectors are identical in all respects except for the 
targeting peptides attached. For this reason, the variation can only be explained by 
the different signaling pathways the proteins would be targeted to and indicates a 
possible protection from degradation in different compartments of the cell. 
We thus sought to determine if a similar differential pattern III L2 protein 
expression was seen when using the different pTRA vectors. 
As mentioned previously, the different pTRA vectors fuse signaling peptides that 
target the protein to various compartments within the plant cell. The pTRAc does 
not attach a signal to the protein and thus as a default the protein is thought to be 
targeted to the cytoplasm. The pTRAkc-A vector attaches a secretory signal (LPH) 
to the N-terminus which targets the protein along the secretory pathway and is 
assumed to be targeted to the apoplastic space. The pTRAkc-ERH vector also 
attaches the same secretory signal to the N-terminus but in addition attaches a 
KDEL sequence to the C-terminus which serves to retard the protein in the ER. 
The pTRAkc-rbcs l-cTP attaches a chloroplast transit peptide to the N-terminus 
and is thus assumed to target the protein to the chloroplast. 
In addition to the Agrobacterium clone containing pTRA-hL2-C, clones were 
made that contain the humanized L2 (hL2) gene within the pTRAkc-A, pTRAkc-
ERH and pTRAkc-rbcs l-cTP vectors; creating the plasmids pTRA-hL2-A, pTRA-
hL2-E and pTRA-hL2-P, respectively. These clones were infiltrated into two week 
old N. benthamiana and protein was extracted in 8M urea at various time points 
after initially weighing them to ensure all leaf material was standardized. Presence 
of L2 in the samples was detected using western blot analysis (Fig. 7). 200 ng of 
E. coli-expressed L2 was also loaded to confirm the L2 band which was not 
present in the negative control (non-infiltrated plant material) (Fig. 7). All SDS-
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Interestingly, a doublet of the L2 band can be seen in the chloroplast targeted 
expression (pTRA-hL2-P) (Fig. 5C). This phenomenon was seen in all westerns 
containing this sample and can be explained by the presence of the chloroplast-
targeting signal. The signal is 58 amino acids in size and so is big enough to alter 
the migration pattern. In addition once the protein enters the chloroplast this signal 
is cleaved off. Therefore two bands corresponding to L2 would be expected if the 
protein was indeed targeted to the chloroplast. 
These results indicate no difference between expression of L2 when incorporated 
into the different pTRA vectors. In addition, the migration pattern of L2 in pTRA-
hL2-P samples indicates the protein is being targeted to the chloroplast. 
2.3.7 In silica predictions of L2 targeting with attached signal 
peptides. 
Having confirmed no difference in expressIOn of L2 when using the different 
pTRA vectors we sought to determine possible reasons for this. More specifically, 
we hypothesized that the reason expression was not variable between the different 
vectors was because signaling peptides, such as a nuclear localization signal 
(NLS) within the L2 protein were interfering with targeting. Consequently, we 
thought, the L2 protein was in fact accumulating at the same site independent of 
the attached signal peptides fused to the protein by the pTRA vectors. 
A number of targeting prediction programs exist each using different methods and 
parameters of predicting localization. They essentially rely on datasets of signaling 
peptides from proteins of known localizations and search for sequence homology 
between these and the user-defined sequence. These programs also differ in the 
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comparlments lh",y are abk 10 predicl locuti.wlion 10 (39). Sev~n programs w",r~ 
used in this study that arc freely avai lable to the public through the internet. They 
include Prolein I'rowk-r (hllp: /ipprowler.imb.uq.~du.aui ind~:I..jsp). TargdP (http:// 
',",,\\W .eh,.dtu.dkiservice~rrargetP). Si gna t I' (hllp:i h~ IV", .cbs.dl u.d\v'servko:si Sig 
nail' J. MitoProl II (hllp: iiihg.gstdO:iihgimiloproLhtml). Predotar (hllp:/iurgi. 
Yersai lies. inra. fi"/predotariprcdotar .htm I) and Suh 1.0.: (hllp:/ /W\\W .bioinfo. 
ls inghuu. ~du.m/SubLoc). 
Th", amino acid sequo:nces of the signa ling pcptides wero: attached to the sequence 
of the HPV-16 L2 prolein in silica using DNAMAN (Fig. !\). These s<'qll<:nces 
w",r<' th<'n loaded as user-ddined sequences in all of the program, and 
suhsequently -'blasted" to prcdicl thc localizalion with lh", organism spccifiL-o as 
planl in all programs. TIl<: outpll1 formats difkr across the programs; however. I 
have lak",n the qualitative inlilfma!ion giv",n by <'ach of them (Table 4 ). 
HPY-1 6 l2 
Prott:!ln from pTRAc 
LPH 
Protein from pTRAk/;·A 
LPH KDEL 
Prote in from pTRAkc·ERH 
CTP HPV-16 L2 
Protein from pTRAkc-rb<:s1-<;TP 
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Figure 8. A diagrammatic view of the L2 protein with attached signaling peptides. The 
secretory signal (LPH) from the pTRAkc-A and pTRAkc-ERH vectors is attached to the N-
terminus. The pTRAkc-ERH vector further attaches a KDEL sequence at the C-terminus to retain 
the protein in the ER. The pTRAkc-rbcs l-cTP vector attaches a chloroplast targeting signal 
(CTP) to the N-terminus of the protein. 
Table 4: The qualitative information obtained from the various targeting prediction 
programs. 
Prediction L2 protein LPH + L2 + 
LPH+L2 cTP+ L2 
Program alone KDEL 
Protein Prowler Mito Sec/Mito Sec/Mito Chlo 
TargetP XXX XXX XXX Chlo 
SignalP none Sec Sec none 
SubLoc XXX ExCe11 ExCelI XXX 
Predotar XXX ER ER Chlo 
MitoProt II Mito Mito Mito Mito 
I have removed predictions that I did not consider reliable. This was facilitated by 
creating parameters I considered relevant to determine accuracy. These included: 
the setting of specificity at 0.9 for TargetP which excluded the results of 3 of the 
amino acid sequences from being included (indicated by XXX) (Table 4). For 
SubLoc if the expected accuracy was below 70% it was excluded (marked by 
XXX in table 4). IfPredotar predicted the localization to be "elsewhere" it too was 
not considered (also marked by XXX in table 4). If the percentage probability of 
the protein being targeted to the mitochondria in MitoProt II was below 0.7 it too 
was removed. 
Upon analysis of the results two of the programs predicted the L2 protein alone 
may be targeted to the mitochondria (Mito), but one (MitoProt II) seems to 
indiscriminately assign this same prediction to all the sequences. There is a 
plausible reason for this, however; MitoProt II can only predict the probability of 
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targeting to the mitochondria. Consequently, it predicts the same mitochondrial 
targeting peptide in all the sequences as the signal is within the N-terminus of the 
L2 protein which it consistently recognizes. It fails however, to recognize other 
signals that may influence targeting such as a chloroplast transit peptide or 
secretory signal. 
The sequences from the pTRA-hL2-A and pTRA-hL2-E vectors indicate targeting 
along the secretory pathway (ExCell, Sec, ER). A signal peptide, responsible for 
secretion, was found by SignalP in both these sequences at the position of the 
LPH. Interestingly, TargetP, which is closely linked to SignalP, failed to recognize 
this signal peptide and indicated targeting to the mitochondria instead (although 
the value was below the accepted parameter). This same phenomenon was found 
in Protein Prowler. 
This indicates that the two targeting peptides may be competing. Moreover, where 
the target group was changed from plant to animal; recognition of the 
mitochondrial-targeting peptide was removed, indicating specific targeting in plant 
cells. Most of the programs analyze the N-terminal region only, making a 
distinction of the sequence containing KDEL difficult from those which do not. 
However, it is well established in the literature that if a KDEL sequence is present 
and the protein is in the ER it will be retarded. 
Finally, most of the programs specifically recognized the chloroplast transit 
peptide attached to the N-terminus of the sequence derived from pTRA-hL2-P, 
with all confidently predicting targeting to the chloroplast. 
In summary, these results suggest that the L2 protein alone when in the plant cell 
is targeted to the mitochondria by a strong targeting peptide within the N-terminus 
of the protein. Furthermore, they indicate that when the LPH signal is attached it 
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may conflict with the mitochondrion targeting and thus it is questionable which 
targeting succeeds over the other. From the prediction programs it is difficult to 
say whether the KDEL sequence has influenced the results but it can be assumed 
that if the protein finds itself in the ER it will be retarded by this sequence. Lastly, 
with attachment of the chloroplast transit peptide it appears that L2 will be 
targeted to the chloroplast. 
2.3.8 Electron Microscopy to elucidate targeting of L2 in the 
plant cell. 
Having established potential sites for targeting through in silica prediction we 
sought to determine if these can be verified through empirical data. 
Two-week old N. benthamiana plants were infiltrated with the vanous 
Agrabacterium clones containing plasmids pTRA-hL2-A, pTRA-hL2-E, pTRA-
hL2-C and pTRA-hL2-P. plant material was fixed with gluteraldehyde and 
dehydrated at 5 dpi. Samples were then embedded in LR white resin and 90 nm 
sections were made using the microtome. Sections were loaded onto Nickel grids 
that had been coated with butivar. These were subsequently immunolabelled for 
L2 with the polyclonal rabbit a-L2 antibody and monoclonal goat a-rabbit 
conjugated with 10 nm gold particles as the primary and secondary antibodies 
respectively. Electron micrographs were visualized using the transmission electron 
microscope. Sections were analyzed for clearly defined gold label indicating 
presence of L2. 
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Label was found to be present in sections obtained from leaf material infiltrated 
with pTRA-hL2-C (Fig. 9). The integrity of cells was found to be sufficiently 
preserved evidenced by the intact cells with large central vacuoles and surrounding 
plant structures presumed to be various plastids (Fig. 9A). Upon closer 
magnification of the area enclosed in the black box of figure 9A specific label can 
be seen to accumulate within a membrane-bound organelle (Fig. 9B). This 
suggests the possibility of the L2 protein being targeted to a specific organelle. It 
may be speculated to be a mitochondrion as it is smaller than surrounding 
organelles which could represent chloroplasts of which, in addition, there are more 
present in the cell. Specific label was, however, also found in the cytoplasm of 
various samples (Fig. 9C). 
In the leaf material infiltrated with pTRA-hL2-P specific label was consistently 
found to be located to an organelle structure (Fig. 9D). The presence of thylakoid 
membranes within the structure confirms the organelle to be a chloroplast. 
Specific label was found both within and outside of the chloroplast confirming 
earlier results of western analysis (Fig. 9D). Interestingly, the large, central, clear 
area within the chloroplast was found to be present in samples infiltrated with 
pTRA-hL2-P and absent in leaf material from non-infiltrated plants and plants 
infiltrated with the other clones. In addition, specific label was commonly found 
within this clear area. At first it was presumed to be an artifact and thought to 
occur as a result of the resin splitting in certain areas. However, this phenomenon 
was consistently found in subsequent results with the clear area always being 
perfectly enclosed within the chloroplast and only when infiltrated with the pTRA-
hL2-P clone. We thus suggest that the area is in fact a result of accumulation of the 
L2 protein within the chloroplast. 
Leaf material obtained from infiltration with pTRA-hL2-A and pTRA-hL2-E were 
also analyzed by electron microscopy. However, no conclusive information as to 
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their specific targeting could be obtained. In the case ofpTRA-hL2-A this may be 
as a result of where it is presumed to be targeted, namely the apoplastic space. Due 
to the dense nature of cell walls they appear as thick black lines in an electron 
micrograph. This makes it impossible to determine a clearly defined label in 
between the cell walls. In the case of material infiltrated with pTRA-hL2-E 
samples indicated targeting to the cytoplasm, however, the amount of label was 
found to be dramatically low and close to the number of non-specific label found 
in the non-infiltrated material. For this reason the results were excluded. 
In summary, these results suggest the localization of the L2 protein with no 
attached targeting peptides is either the cytoplasm or possibly a membrane 
enclosed vacuole or organelle which may be mitochondria. L2 protein with an 
attached chloroplast transit peptide is localized to the chloroplast where it 
accumulates. Localization of the L2 protein with either the LPH signal alone or in 
addition to the KDEL sequence needs to still be determined. 
2.3.9 Co-expression of L 1 and L2 in plants. 
As previously mentioned L 1 contains the intrinsic knowledge to form virus-like 
particles that mimic the HPV virion structure and so provide a perfect candidate 
for a vaccine (17). L2 has been found to enhance VLP formation when co-
expressed with Ll in mammalian cells (17,38). In addition, Ll expressed alone in 
plants has been found to form VLPs (6,54). Having sufficiently characterized the 
expression of L2 in plants we turned our attention in assessing whether it is 
possible to form full VLPs that incorporate L2 when co-expressed with L 1 in 
plants. 
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determine the location of VLPs III fractions and plant material with L2 alone 
served as a negative control to determine if the presence of L2 in a VLP fraction is 
due to the VLP or to another factor. 
VLPs were extracted using two different methods; butanol and high salt PBS. 
These were later pelleted at high speed (55K rpm). An L2 signal was detected, 
using western blot analysis, in the pellet of plant material that was co-infiltrated 
with L 1. However, an L2-specific signal was also seen in the pellet derived from 
plant material infiltrated with L2 alone. This suggests that the presence of L2 in 
the VLP pellet may be due to another reason other than incorporation into the 
VLP. 
An alternative method was thus attempted, namely immunoprecipitation. An 
antibody that recognizes L 1 molecules and more importantly VLPs was provided 
and used for immunoprecipitation. This antibody serves as an 
immunoprecipitating antibody binding specifically to the VLPs. Protein A 
specifically binds to the F AB of any antibodies thus when conjugated to agarose 
can be used to specifically precipitate a molecule that an antibody is bound to. The 
idea was to immnoprecipitate VLPs from solution and test for L2 using western 
blot detection. The immunoprecipitation antibody was derived from guinea pig so 
to not interfere with the western blot later used for detection. An L2 signal was 
seen in the immunoprecipitated sample of L2 and L I expressed plant material, 
however, this signal was also seen in the L2 expressed alone plant material. Again, 
suggesting an alternative reason for the L2 being present in the VLP pellet. 
Finally, sucrose gradient fractionation was also used to separate VLPs in solution 
from protein molecules. This form of separation is more sensitive than the others 
used thus by creating a density gradient so molecules of various sizes can be 
distinguished. In this way the less dense single molecules of L2 and L I can be 
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separated from the denser VLPs. Plant material was again extracted in high salt 
PBS and run in a 5-50% sucrose gradient. Fractions of L2 and L I expressing plant 
material were analyzed by L2 dot blot - L2 was again found to be present in every 
fraction. In addition, the L2 alone fractions produced a similar pattern. An L2 
ELISA was also attempted using these fractions; however the same problems as 
previously encountered of no detection or interference was found. 
Therefore these results indicate that L I and L2 can be successfully co-expressed in 
the same cell in the plant. However, whether or not they form VLPs that 
incorporate L2 is unclear. In addition, the presence of L2 at various densities is a 
further problem that needs to be addressed. 
2.4 Discussion 
Due to the relatively new technology of transient expression an investigation into 
its limiting factors was required before the technique could be objectively used. 
Post-transcriptional gene silencing (PTGS) is a major limiting factor of transient 
expression in plants, with various silencing suppressors having been characterized 
in a number of plant viruses (90). These act in different ways and at different 
points within the system. For example, the NSs protein inhibits the functioning of 
the RNAse III-like protein from making siRNAs (75). In addition, pI9 prevents 
association of siRNAs with the dicer nucleases (84). The results in this study show 
the infiltration procedure to be effective, silencing to be suppressed with a 
silencing suppressor, and the transient expression system to be viable. For these 
reasons a silencing suppressor was subsequently used in every infiltration. 
The L 1 gene expressIon was limited in mammalian cells when coded by the 
wildtype gene which was subsequently overcome by codon optimization (58). 
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Expression of L I was similarly unable to be detected in plants at the protein level 
when coded by the L I wildtype or plantized gene (7). In both this lab and others 
expression of L 1 in plants was confirmed to dramatically increase when coded for 
by a mammalian-codon optimized form of the Ll gene (7).We sought to determine 
if the L2 gene follows a similar pattern of limited protein expression when coded 
by the wildtype and plantized gene and proposed that a similar increase in L2 
protein expression would be seen when coded for by the equivalent mammalian-
codon optimized L2 gene. 
The results show a comparatively similar pattern of protein expression between Ll 
and L2; however, some differences were apparent. Our lab has shown marginal 
expression of L 1 utilizing the wildtype gene (54), contrary to a previous 
publication (6) - such a discrepancy could be due to different methods used and 
different expression vectors employed. In addition, no expression of L 1 protein 
was seen when coded by the plantized version of the gene. In the case of L2, no 
protein expression was detectable when coded for by the wildtype or plantized 
sequence of the gene. Expression was seen, however, when coded for by the 
humanized sequence of the gene. This prompted an enquiry at the RNA level to 
elucidate at what stage expression is limited. 
Real time PCR (RT-PCR) is a relatively new technique and as such is prone to a 
number of difficulties. Due to the sensitive nature of RT-PCR, stability of the 
template is paramount, particularly when the same template is to be used in two or 
even three separate batches of reactions. For this reason we chose to convert the 
mRNA to cDNA which is notably more stable and easier to work with. In 
addition, the technique utilizes complicated empirical formulae that would confuse 
even an ardent biological statistician. This requires, in tum, disciplined 
optimization and the acceptance of a large portion of troubleshooting (53). 
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This, in turn, necessitates stringent parameters set by the researcher to evaluate 
which results they feel confident about presenting. In this study, I chose to limit 
the results to those that fell into the parameters I set for the standard curve and the 
melt curve. This consequently led to a number of experiments being discarded 
which may otherwise exaggerate the results presented in this study. Such an 
example would be where the concentration found in a separate set of results would 
dramatically increase the error bars either side of the mean but the calculated 
concentration did not lie within two points of the standards used or an extra peak 
was found within the melt curve. For this reason these results can only be termed 
preliminary as they have yet to be verified by further reactions and so be 
statistically validated by reproducibility. 
An alternative to addressing this problem would be to use the MeT method of 
quantification. This negates the need for a standard curve to be generated in each 
experiment and is relatively simpler to develop and optimize (53). It requires an 
initial construction of standard curves of all the genes of interest and the reference 
gene (2). Then a determination of the efficiencies of the reactions which takes into 
account that different primers and templates will have different kinetics with 
changes in template amounts (2). If, when plotted the efficiencies are determined 
to be comparable this method can be used with confidence (2). However, if they 
are not comparable then a normalization factor is determined to take into account 
the variation in efficiencies (2). However, it needs to be accepted that a certain 
percentage of error will still be present, but this may also be addressed by certain 
programs such as REST that take this error into account (40). This method may 
solve or negate some of the problems found in this study but due to the presence of 
a percentage of error it may also create some. 
Ultimately, despite the fact that these results can only be termed preliminary they 
do nevertheless represent a trend that was present throughout the analysis. 
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Specifically, that the pL2 gene consistently had the lowest levels of mRNA in 
comparison to the other L2 genes. A possible reason for this may be linked to the 
plants own immune response system. 
It is well known that siRNAs are used in both plants and animals as part of an 
immune response to limit viral infection through PTGS (89). In addition, the plant 
utilizes endogenous siRNAs to regulate gene expression (91). It is uncontestable 
that the various L2 genes are exogenous genes within the plant cell and so are 
susceptible to degradation through the PTGS system in much the same way as 
plant viral genes. However, with the addition of p 19 or NSs this pathway is 
disrupted. But the endogenous siRNA pool may not be disrupted as the siRNAs 
were already present and so able to associate with the nucleases to give them site 
specificity prior to addition of either of these suppressors. Thus, I hypothesize that 
the exogenous genes are still susceptible to endogenous siRNAs if they share any 
sequence homology. 
The process of optimizing a gene for expression in a particular system involves the 
changing of the codons of the gene to those that are more commonly recognized in 
the cells of that system. Thus, it is possible that in optimizing the L2 gene for 
expression in plants, in this case specifically for Nicotiana benthamiana has lead 
to an increased chance of the endogenous siRNAs having sequence homology with 
the gene. This theory is also supported by the findings that L 1 expression is 
markedly decreased when coded by a plantized version of the gene in comparison 
to the wildtype and humanized versions (54). 
An obvious flaw in the ASRP analysis is the fact that these siRNAs are from 
Arabidopsis and not tobacco. It is important to remember that the tobacco genome 
has yet to be sequenced and so can be thought to be evolutionarily impaired with 
respect to scientific knowledge in comparison to Arabidopsis. Thus, a comparable 
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type of application that contains a database of tobacco siRNAs is still a 
considerable time away. However, this should not prevent a certain amount of 
inference from the data. In addition, statistically-speaking if you consider the three 
different L2 genes to be random sequences they would each have as much chance 
of having the same number of hits. This, however, was not the case and the 
plantized L2 sequence was found to have a higher number of probable binding 
sites than the wildtype or humanized sequences. 
Consequently, I believe I have managed to construct a plausible theory of why the 
wildtype and plantized L2 genes are not very well expressed in plants in 
comparison to the humanized version of the gene. I postulate that the negative 
RNA elements present within the wildtype L2 gene prevent expression in plants. 
This relies on an arguable premise that similar negative RNA element systems 
exist between plants and animals, of which I have found no supporting evidence in 
the literature. It is plausible, however, if the negative elements form structural 
inhibitions preventing ribosomal binding or read-through thus limiting expression. 
As opposed to a system where specific translational regulating factors that 
recognize the region and aid inhibition, in which case similar proteins that 
recognize the same sequence in both animals and plants is unlikely. 
Thus, assummg the negative elements are recognized within the plant cell; a 
change in sequence should remove these elements. This is the case for both the 
plantized L2 (pL2) and the humanized L2. However, when coded for by the pL2 
gene detectable levels of the protein are not realized. A reason, I believe, is due to 
the increased probability of small endogenous RNAs binding to the gene as a 
result of optimizing the gene to be more similar to the endogenous plant genes. 
Finally, I propose that hL2 is successfully expressed as it changes the sequence of 
the wildtype gene to remove the negative RNA elements. In addition, it is 
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sufficiently different to endogenous plant genes to not be recognized by the small 
endogenous RNAs that would otherwise preferentially target it for degradation. 
Turning then to the protein expression of L2 when coded for by the humanized 
gene cloned into the various pTRA vectors we noticed no differential pattern in 
expression. This contradicts with the parallel expression pattern of L 1 when using 
the different pTRA vectors (54). Expression levels of Ll when coded for by the 
humanized version of the gene were 533 mg.kg- 1 of plant material and 379.9 
mg.kg- 1 when cloned into the pTRAkc-rbcsl-cTP and pTRAc vectors, respectively 
(54). In addition, the expression levels of L 1 when targeted to the ER were found 
to be dramatically lower (54). 
In comparison we estimate the expression levels of L2 to be roughly 25 mg.kg- 1 
irrespective of which vector was used. However, it must be acknowledged that this 
value is purely an estimate and has as yet to confirmed by additional, more reliable 
and sensitive quantifying techniques such as ELISA. These results do, 
nevertheless, represent a general trend that was consistently observed, namely 
expression of L2 does not vary across the different pTRA vectors. 
A possible reason to explain the different expression patterns seen with L 1 when 
utilizing the various pTRA vectors is that the protein is targeted to different sites 
within the plant cell that confer either more or less protection. Concurrently, the 
fact that expression of L2 does not vary with the different pTRA vectors may 
indicate targeting to the same site or to different sites that confer equal protection. 
In an attempt to answer this question we used two methods to devise a theory of 
where the protein is being targeted in vivo. These were to use in silica predictions 
which could either be confirmed or refuted through electron microscopy. 
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Protein targeting signals have only recently been characterized with the Nobel 
prize being awarded to their discoverer in 1999 (27). With the advent of high-
throughput techniques localizations of many proteins have been subsequently 
discovered (27). By combining this data and computational power various 
prediction programs have become available. But, it must be noted that these 
programs can only serve as preliminary data with a certain expected degree of 
accuracy. This is evidenced in Heazlewood et al. which compared experimental 
and predicted datasets of various Arabidopsis genes (39). Interestingly, they found, 
on average, prediction programs conflicted with experimental data 50% of the 
time, with some achieving 70% accuracy upon prediction (39). It must be noted, 
however, that even amongst different experimental data there were also many 
contradictions as to localization (39). This highlights a degree of discretion to be 
used when looking at both predicted data and experimental data. 
The prediction programs used indicated the presence of a mitochondrial signal 
within the N-terminus of the L2 protein. Interestingly, when the programs which 
allowed for a change in defining the organism of origin, i.e. the user can set 
whether they wish to use plant sequences or animal sequences, this mitochondrial 
signal was not recognized when animal sequences were used. This indicates a 
specific plant mitochondrial signal. Thus the prediction data does not conflict with 
previous findings in animal expression systems where L2 was not seen to be 
targeted to the mitochondrion. It is possible that this mitochondrial signal may 
conflict with other signals present in the protein attached by the other pTRA 
vectors, such as the LPH, KDEL and cTP. In an attempt to confirm or refute this 
hypothesis we turned to electron microscopy. 
Electron mIcroscopy IS an inherently difficult technique to master as any 
technician sitting before a microtome "scooping up" microscopic ribbons can 
confirm. A number of trade-offs need to be assessed, such as, what degree of 
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distortion is permissible to obtain a general snap shot of the cell versus a 
cumbersome method to attain a perfect snap shot. We chose to use gluteraldehyde 
fixation which cross-links all proteins in the cell and mounted the samples in LR 
white resin necessary for our purposes of immunolabelling. Our polyclonal rabbit 
a-L2 antibody was used to initially label the L2 protein and monoclonal goat a-
rabbit conjugated with 10 nm gold particles was used as the secondary antibody. 
This gold particle is important as it does not allow electrons to pass through it and 
is bigger than the proteins thus allowing specific visualization of the target protein. 
We chose to use Nickel grids coated with butivar as initial experiments found our 
sample unable to be preserved sufficiently with uncoated grids. 
In addition, it is important to remember that an electron micrograph (EM) is a snap 
shot of the cell and as such any results could indicate a step within the targeting 
pathway as the protein is on its way to a different compartment. The snap shot 
analogy becomes particularly relevant when considering the number of variables 
implicit in immunolabelling. First, the leaf sample needs to be sufficiently 
preserved and embedded. Secondly, when sectioning the plane of the sample 
becomes relevant and affects what structures will be visible. Lastly, the section 
needs to be taken in a plane that allows exposure of an epitope that allows for 
recognition and binding by the antibody. 
With this in mind EMs of plant material suggest the L2 protein alone (without 
targeting signals) is present in the cytoplasm. They further indicate the possibility 
of targeting to a membrane-sac that may be a mitochondrion. With the attachment 
of a chloroplast transit peptide to L2 it appears the protein is localized to the 
chloroplast. Unfortunately EMs to elucidate targeting of L2 when the LPH is 
attached with or without the KDEL sequence proved inconclusive. 
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Accumulatively these results allow the surmise of a hypothesis of targeting which 
may explain the pattern of expression. I suggest that the mitochondrial signal 
present in L2 is recognized within the plant cell and thus targets it to the 
mitochondrion. In addition, this signal interferes with the secretory signal (LPH) 
and thus the protein does not follow the secretory pathway instead also localizing 
to the mitochondrion. Thus, the protein may not be targeted to the ER and so the 
KDEL sequence cannot act to retain it therein. The cTP signal, however, is strong 
enough to overcome the mitochondrial targeting and so L2 accumulates in the 
chloroplast when attached. I surmise that similar expression levels are seen as both 
the mitochondrion and chloroplast confer similar protection to allow accumulation 
of the protein. 
Finally, turning to co-expression of L 1 and L2 in this system necessitates an initial 
exploration of co-expression in mammalian systems which have shown the ability 
of producing VLPs that incorporate L2 (37). Interestingly, VLPs produced from 
co-expression of L2 were found to be less variable in size, leading to speculation 
that L2 enhances capsid formation (37) (as mentioned in Chapter 1). In this lab 
and others, VLPs have been shown to form when L 1 is expressed alone in plants 
(7,54). We hypothesized that L 1 co-expressed with L2 in plants would lead to 
VLPs incorporating L2 and a similar enhancement of VLP formation as seen in 
mammalian cells. 
Our results indicate that L2 and L 1 can successfully be co-expressed in the same 
plant. It is probable that both proteins are able to be present in the same plant cell 
based on corollary findings that antibodies with separate constituent parts can be 
formed within the same cell (33,49). However, whether Ll and L2 are able to form 
full VLPs that incorporate L2 is unclear. We consistently found L2 alone to 
sediment with the higher density VLPs and present at various densities within the 
sucrose gradient fractions. A possible explanation for this may be that L2 forms 
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aggregates in the high salt buffer used; a problem not previously encountered due 
to the use of 8M urea in prior isolation of L2. This same problem was encountered 
within this lab when L2 was expressed in E. coli; hence the use of 8M urea in all 
experiments. 
Butanol extraction relies on the separation of all aqueous molecules from non-
polar substances such as polyphenols. In theory, the VLPs and L2 protein should 
be found in the aqueous phase and the commonly interfering substances of plant 
material to be separated into the non-polar phase. Unfortunately, this extraction 
method did not seem to improve our results. 
These results indicate a good starting point from which to begin to investigate the 
feasibility of a plant-produced HPV L lIL2 vaccine. It is clear that alternative 
buffers should be assessed that solubilize and preserve the VLPs and in addition 
that solubilize L2. Whether butanol extraction should be subsequently used 
remains unsure, however, if no dramatic loss in protein is detected it could be an 
invaluable method of removing plant material that interferes with downstream 
applications. 
2.5 Conclusion 
I found it is possible to express L2 in plants, with expression being best when 
coded for by the mammalian codon optimized sequence of the gene. In addition, 
they indicate that high levels of co-expression of L 1 and L2 are possible through 
transient expression making the likelihood of VLPs that incorporate L2 highly 
probable. 
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Further investigations should target, first, the quantitation of L2 protein expression 
within this system which necessitates improved extraction and solubilization of 
undenatured L2. This will have a knock on effect on the L2 ELISA in possibly 
allowing detection of small quantities without interference of plant material. In 
addition, another monoclonal or polyclonal 0'.-L2 antibody should be sourced 
which would allow the use of the capture ELISA method known to be more 
sensitive and remove the problem of interfering plant products. 
Secondly, additional RT peR experiments should be completed to confirm the 
results represented in this study. This may include a different or even concurrent 
approach to RNA quantitation using a different calculation method, such as the 
MeT method. 
Thirdly, additional electron micrographs should be completed to determine 
localization of the ER-targeted and apoplastic-targeted L2. Alternative methods 
may also be utilized such as immunofluorescence which uses a secondary antibody 
attached to a fluorophore. However, due to the use of spectrometry as opposed to 
electron microscopy less detail will be visible, but it may allow determination of 
localization of the apoplastic-targeted protein between the cell walls. 
Finally, extraction and separation methods of VLPs needs to be refined to remove 
the false positive seen in the L2 alone expressed material. This would allow 
confirmation of L I /L2 VLPs. This may include a series of different buffers that 
have various pHs, different salt concentrations and/or possible additional agents 
that may aid solubility, such as various ionic and non-ionic detergents. 
The immunogenic properties of L2 and stabilizing properties with respect to VLPs 
make L2 an attractive recombinantly expressed vaccine or vaccine enhancer, 
respectively or in addition. Thus, these results in combination with the cheaper 
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expression system of plant production represent the initial steps needed III 
realizing a cheaper HPV vaccine for developing countries. 
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